Reports Show Increasing Amount Of “ËœE-Waste’

An upcoming report from the Basel Convention on transboundary movement of hazardous waste is said to show a “catastrophic accumulation of e-waste” that could prove to be hazardous.

“I’d say its something in the region of six billion tons, it’s a rough estimate,” said Katharina Kummer Peiry, executive secretary of the international agreement.

“E-waste did not even exist as a waste stream in 1989 and now it’s one of the largest and growing exponentially,” Peiry said.

The AFP reported that a UN Environment Program report found that the pileup of e-waste could soon reach 50 million tons per year.

“Add an increasing demand for electronic gaming, higher definition televisions or smart cars, and the result is a catastrophic accumulation of e-waste, now and into the future,” said the Basel Convention.

In late October, Indian officials held a two-day International Conference on Heavy metals and E-waste in New Delhi, during which Priti Mahesh, senior program officer of Toxic Link said e-waste is a “major problem and growing at the rate of 10 to 15 percent annually.”

“We think by 2010, the e-waste in India will go up to 800,000 tons,” said Mahesh.

With just six regular recycling facilities, India has only an annual recycling capacity of 27,000 tons, according to pollution control officials.

“The unmitigated use of heavy metals and toxics has a long-standing and far-reaching impact on the planet. It impacts our environment and human health directly. Sustainable and safe alternatives need to replace these dangerous chemicals immediately to safeguard the planet”, said Ravi Agarwal, Director of Toxic Link.

The group also found that as workers with bare hands dissemble e-waste, many of them become exposed to dangerous metals such as barium, lead, copper and cadmium.

“It’s already a problem and on its way to becoming worse because 97 percent of waste gets recycled in hazardous conditions,” said Mahesh.

On the Net:

Preschoolers Want Explanations

Curiosity plays a big part in preschoolers’ lives. A new study that explored why young children ask so many “why” questions concludes that children are motivated by a desire for explanation.

The study, by researchers at the University of Michigan, appears in the November/December 2009 issue of the journal Child Development.

The researchers carried out two studies of 2- to 5-year-olds, focusing on their “how” and “why” questions, as well as their requests for explanatory information, and looking carefully at the children’s reactions to the answers they received from adults. In the first study, the researchers examined longitudinal transcripts of six children’s everyday conversations with parents, siblings, and visitors at home from ages 2 to 4. In the second study, they looked at the laboratory-based conversations of 42 preschoolers, using toys, storybooks, and videos to prompt the children, ages 3 to 5, to ask questions.

By looking at how the children reacted to the answers they received to their questions, the researchers found that children seem to be more satisfied when they receive an explanatory answer than when they do not. In both studies, when preschoolers got an explanation, they seemed satisfied (they agreed or asked a new follow-up question). But when they got answers that weren’t explanations, they seemed dissatisfied and were more likely to repeat their original question or provide an alternative explanation.

“Examining conversational exchanges, and in particular children’s reactions to the different types of information they get from adults in response to their own requests, confirms that young children are motivated to actively seek explanations,” according to the researchers. “They use specific conversational strategies to obtain that information. When preschoolers ask ‘why’ questions, they’re not merely trying to prolong conversation, they’re trying to get to the bottom of things.”

The moderate sample size means that the study cannot be generalized to all children, but the research clearly suggests that by age 2, children contribute actively to the process of learning about the world around them.

The study was funded, in part, by the National Science Foundation and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Summarized from Child Development, Vol. 80, Issue 6, Preschoolers’ Search for Explanatory Information Within Adult-Child Conversation by Frazier, BN, Gelman, SA, and Wellman, HM (University of Michigan). Copyright 2009 The Society for Research in Child Development, Inc. All rights reserved.

On the Net:

Surgeon ‘Gluing’ The Breastbone Together After Open-Heart Surgery

Technique developed at the University of Calgary

An innovative method is being used to repair the breastbone after it is intentionally broken to provide access to the heart during open-heart surgery. The technique uses a state-of-the-art adhesive that rapidly bonds to bone and accelerates the recovery process.

“We can now heal the breastbone in hours instead of weeks after open-heart surgery. Patients can make a full recovery after surgery and get back to full physical activities in days instead of months,” reports Dr. Paul W.M. Fedak, MD PhD FRCSC, a cardiac surgeon at Foothills Medical Centre and scientist at the Faculty of Medicine who pioneered the new procedure.

Over 20 patients have received the new technique in Calgary as part of a pilot study. Fedak and Kathryn King, RN PhD are the co-principal investigators on the study. King, a cardiovascular nurse scientist, is an expert in post-operative recovery after open-heart surgery. “We know that recovery from sternotomy is a multi-faceted process that includes not only healing of the breastbone but the ability to return to normal activities,” she says. “Being able to resume normal activities is a hallmark of a good recovery; this surgical innovation should enable that.”

The patients report substantially less pain and discomfort after surgery and the use of strong pain medication, such as narcotics, is profoundly reduced if not completely eliminated with use of the procedure. The ability to deep breathe, known to play a key role in recovery, is also substantially improved.

Richard Cuming’s chest was repaired in June KryptoniteTM adhesive, a biocompatible polymer (manufactured by Doctors Research Group Inc., (Connecticut USA). Two years earlier he had open-heart surgery repaired the traditional way ““ sewing his breastbone back together with wire. That wire broke, his breastbone opened, and Cuming had a difficult time.

“I couldn’t accomplish simple tasks like squeezing toothpaste, turning the steering wheel in my car or pulling open a heavy door without discomfort and pain. Anytime I coughed or sneezed there was movement in my chest and significant pain, I think the worst part of the ordeal was that I stopped doing things ‘in case they would hurt'” says Cuming.

After his chest was ‘glued’ back together using KryptoniteTM adhesive and wires he had an entirely different experience. “I had a little bit of pain, but this was a walk in the park compared to my earlier recovery. I can do anything I could do prior to the original surgery. I feel wonderful.”

The encouraging results of this pilot study have prompted the Calgary researchers to establish a worldwide study to further investigate its benefits. The STICK Trial (STernal Innovative Closure with KryptoniteTM) aims to apply the technique in over 500 patients across the globe over the next 12 ““ 24 months.

“We are proud of the innovative work being done at Foothills Medical Centre,” says Dr. L. Brent Mitchell, Director of the Libin Cardiovascular Institute of Alberta and Head of the Clinical Department of Cardiac Sciences at Alberta Health Services, “I used to warn my open-heart surgery patients that they would feel like they had been hit by a truck during a long recovery period; I’m glad I don’t have to say that anymore.”

More than one million open-heart surgeries are performed in the world each year by splitting the breastbone. Until this recent discovery, wire closure of the breastbone had been standard practice since routine heart surgery was established a half century ago.

The investigators believe that this improved method of chest closure will become a new standard of care for patients undergoing open-heart surgery. Fedak has started training surgeons in other Canadian and European hospitals where it is rapidly gaining popularity.

KryptoniteTM is approved for use in Canada (Health Canada), USA (FDA), and Europe (CE Mark). This pilot study has been supported in part by Doctor’s Research Group Inc.

Image Caption: Dr. Paul Fedak from the University of Calgary Faculty of Medicine has developed an innovative method to repair the breastbone after it is intentionally broken to provide access to the heart during open-heart surgery. The technique uses a state-of-the-art adhesive that rapidly bonds to bone and accelerates the recovery process. Credit: Paul Rotzinger

On the Net:

Poor Dental Hygiene May Hinder Brain Function

A new study indicates that there may be a link between good oral care and aging adults retaining their mental sharpness, reported Reuters.

Researchers found during the study that adults aged 60 and older with the highest versus the lowest levels of the gum disease-causing pathogen Porphyromonas gingivalis were three times more likely to have a hard time remembering a three-word sequence after a period of time.

Dr. James M. Noble of Columbia College of Physicians and Surgeons in New York City and his team also found that adults with the highest levels of this pathogen were twice as likely to fail three-digit reverse subtraction tests.

The researcher’s findings are published in this month’s edition of the Journal of Neurology, Neurosurgery, and Psychiatry. They are based on over 2300 men and women who were tested for periodontitis and completed many thinking skills tests as part of the National Health and Nutrition Examination Survey III conducted between 1991 and 1994.

The researchers  reported that overall, 5.7 percent of the adults had difficulty finishing certain memory tasks and 6.5 percent failed reverse subtraction tests. The subjects with the highest (greater than 119 units) versus the lowest (57 units or lower) pathogen levels were most likely to do poorly in these tests.

Previous research has already made a strong connection between poor oral health and heart disease, stroke and diabetes, as well as Alzheimer’s disease.

The researchers said that gum disease could have an adverse affect on brain function in several different ways. For example, gum disease is known to cause inflammation throughout the body, a contributing risk factor for the loss of mental function.

Dr. Robert Stewart, of King’s College in London, United Kingdom, made the comment that this study builds on a “quietly accumulating” body of evidence linking oral and dental health with brain function.

On the Net:

Advances In Malaria Research Show Promise For Fight Against 1 Of The World’s Deadliest Diseases

Top scientists reveal the latest innovations in genetically modified mosquitoes, new diagnostic tests and mapping mosquito migrations

In a novel approach at disseminating scientific research, the Johns Hopkins Malaria Research Institute (JHMRI) will hold a web summit to release the latest breakthroughs in malaria research, including new approaches to boosting mosquito immunity to malaria, mapping mosquito migrations, and the promise of a rapid sputum test that could revolutionize the way malaria is tracked and tested for in rural areas, which are hotbeds for the disease.

Each year more than 300 million malaria cases occur worldwide. Nearly one million people die of malaria every year, most of them children. In Africa, malaria is responsible for one in five childhood deaths.

“Many young people today are passionate about global health issues. We want to engage them to pursue scientific careers in the battle against malaria,” says Peter Agre, MD, Nobel Laureate, Director of the JHMRI, and current president of the American Association for the Advancement of Science (AAAS).

Mosquito Immunity to Malaria

George Dimopoulos, PhD, Associate Professor of Molecular Microbiology and Immunology at the JHMRI, will discuss new ways to make mosquitoes’ immune systems resistant to the malaria-causing parasite, Plasmodium falciparum.

“The mosquito is the most dangerous organism in the world after humans. It has killed more than any other higher organism, which is why vector biology and vector research are incredibly important in controlling diseases in developing countries,” says Dimopoulos.

Earlier this year, Dimopoulos’ group identified a molecular pathway that triggers an immune response in multiple mosquito species capable of stopping the development of Plasmodium falciparum. By silencing the gene, caspar, the researchers were able to block the development of the parasite in Anopheles gambiae, A. stephensi and A. albimanus mosquitoes””three mosquito species that spread malaria in Africa, Asia and the Americas.

The process relied on a technique called transient gene silencing, which means that they didn’t make lasting changes to the DNA of a mosquito. Now, Dimopoulos and his team are using genetic modification (GM) to permanently manipulate this particular molecular pathway so that mosquitoes’ bodies will attack, rather than host, the malaria-causing parasite. So far they have successfully produced two lines of GM mosquitoes that work. In one line, the immune pathway gene was expressed in the mosquitoes’ gut tissue (where the parasite enters). in the other line, it was expressed in the organ that functions like a liver, the ‘fat body.’ They now hope to create a strain of GM mosquitoes that will express the immune pathway gene in the gut and the fat body tissue simultaneously, and maximize the potency of this immune response.

“This kind of work is pioneering for malaria,” says Dimopoulos. “These are the first genetically modified mosquitoes that are resistant to the Plasmodium parasite that causes human malaria because of a modification in their immune systems.”

Dimopoulos stresses that as promising as this line of research is, “We still need an arsenal of several control strategies to contain malaria because different tactics will work in different scenarios. In some places, a vaccine may work best, in more remote places, other low cost, low tech approaches will work better. You can’t win a war with the Air Force alone””you need all the branches.”

Marcelo Jacobs-Lorena, PhD, Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, is also working on modifying the mosquito in order to make it a poor vector for the parasite. His lab was the first to introduce genes into the mosquito genome which caused the mosquito to express a Plasmodium-repelling peptide. But spreading these genes into wild populations of mosquitoes has proven challenging. Even though several breeds of mosquitoes can transmit malaria, they don’t cross-breed, so just because researchers can introduce a gene into one population of mosquitoes, it doesn’t mean that another population in the same area will also get that gene.

Now, Jacobs-Lorena is taking a new approach to creating a malaria-resistant mosquito by tinkering with the bacteria that occur naturally in mosquitoes’ guts.

“The idea we are now exploring is how to genetically modify this bacteria so it secretes a substance that is lethal to the Plasmodium parasite, but not to the mosquito,” he explains.

The benefit of cultivating GM bacteria is that it’s much easier to grow large amounts of bacteria than to grow large numbers of mosquitoes. Jacobs-Lorena is currently looking at ways to spread GM bacteria in the wild by creating artificial refuges for mosquitoes containing cotton balls impregnated with sugar and GM bacteria. The theory is that mosquitoes will be drawn to the dark, humid, artificial refuges and get a helping of Plasmodium-killing bacteria while they eat the sugar.

Development of a Non-Invasive Malaria Diagnostic

Sungano Mharakurwa, PhD, Scientific Director of the Malaria Institute at Macha (MIAM) in Zambia, a living laboratory for mosquito and human behavior in malaria-stricken areas, is developing a rapid saliva-based malaria diagnostic test that works without the need for specialized personnel or equipment, and can be used at a grass-roots level.

This new microfluidic device would be affordable to produce in large numbers and would act as a miniature laboratory that could analyze a small spit sample to quickly determine whether or not someone is infected with malaria.

“The safe, affordable, and non-invasive nature of the test would make it an ideal tool for community surveillance and elimination of malaria, especially in children, asymptomatic carriers and communities that have taboos about drawing of blood,” says Mharakurwa.

Current diagnostic tests for malaria come with prohibitions. They require trained health workers to take blood samples, which can only be drawn so often, hindering researchers’ ability to routinely monitor the efficacy of malarial drugs or vaccines.

“In areas like Southern Africa, we need a test that can cover all communities, particularly those regions where many people don’t exhibit symptoms of malaria, even if they carry the disease. These segments can be an inadvertent reservoir for the parasite, and if malaria is pushed down, but not entirely eliminated, it can resurge worse than before,” he says.

Phil Thuma, MD, Managing Director of the Malaria Institute at Macha, says that there has been a remarkable decrease in malaria case load in Macha since the research institute has been carrying out research studies. Thuma believes that credit goes to the remarkable local community cooperation with the research studies and ownership by the community and MIAM staff of the research programs, which has led to a wonderful research working environment. This, coupled with effective tools like insecticide treated bed nets and an effective anti-malarial combination drug based on artemisinin, has helped the fight.

“Malaria control and possible elimination in rural Africa seems very probable, but we need to continue working hard to get there and sustain it. That will take ongoing research studies to better understand the vector and the disease,” says Thuma.

Mapping Mosquito Migrations

Gregory Glass, PhD, Professor of Molecular Microbiology and Immunology and Epidemiology with the Johns Hopkins Bloomberg School of Public Health, uses sophisticated satellite imaging to track populations of mosquitoes to help reduce malaria transmission in Africa.

“We study spatial patterns of malaria risk, using new technology like satellite images to target where the mosquitoes are living and breeding in order to get the biggest bang for the buck for our resources,” says Glass.

He explains that people differ in their risk for contracting malaria based on their local environment””for example, how close they are to malaria breeding grounds. This is the kind of risk that Glass’s group can show with satellite pictures.

In Europe and North America, public health officials control mosquito-borne diseases by carefully monitoring and controlling aquatic breeding sites for mosquitoes. But in sub-Saharan Africa, where there are three vector species and mosquitoes propagate in the likes of watery hoof prints of cattle, controlling mosquito breeding sites is much more difficult.

Satellite images can change this. In Zambia, remote sensing specialists look at satellite data to unearth information about the landscape, like soil moisture, or where water drains to, and bubbles up, in order to identify the most likely breeding places for mosquitoes.
“In Macha, we see some villages where most households are infected with malaria, but six miles away, no one is. Teasing apart this difference will help figure out exactly where to deliver bed nets, medicines and insecticide spray,” says Glass.

About the Web Summit

During an interactive web summit, participants from diverse backgrounds, including undergraduate students, journalists and physicians from around the world will be briefed on the latest findings in the fight against malaria from top researchers at JHMRI, and pose questions in real-time via Twitter. In addition, participants will visit (by video) the JHMRI insectary where mosquitoes are bred, raised and studied at the heart of the Institute’s scientific operations in Baltimore, MD.

Participants will virtually meet researchers who use NASA data to map the movement of deadly malaria-carrying mosquitoes. They’ll also hear from researchers based at the Malaria Institute at Macha.

“The take-home message to students and young scientists is that there’s new hope to eliminate malaria. The tools are there and if we use well-investigated approaches, it’s possible that in their lifetimes they’ll see the end of malaria, at least in certain regions of the world,” says Mharakurwa.

On the Net:

Coffee Compound Brewing New Research In Colon, Breast Cancer

Researcher says no concerns about drinking coffee at this point

A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.

Though the studies have not been conducted to determine recommended consumption amounts, scientists say the compound, called trigonelline or “trig,” may be a factor in estrogen-dependent breast cancer but beneficial against colon cancer development.

“The important thing to get from this is that ‘trig’ has the ability to act like a hormone,” said Dr. Clinton Allred, AgriLife Research nutrition scientist. “So there is a tie to cancer in the sense that we are looking at estrogen-dependent cancer cells. But that doesn’t suggest that it would actually cause the disease. I don’t believe there should be any concern about drinking coffee at this point.”

His report was published in the Journal of Nutrition. Allred’s lab studies dietary compounds that can mimic the hormone estradiol ““ the primary hormone in women. His main focus has been to look at how estrogen protects against the development of colon cancer. Estradiol is one of three estrogen hormones. “There’s a history of these compounds in crops such as soy,” Allred said. “Soy has a number of different compounds that actually can mimic estradiol in several disease states some of which are good and some of which have the potential to be more deleterious-type effects.”

Allred said a former colleague mentioned an interest in finding the properties of “trig” ““ a natural compound used in traditional Indian culture for post-menopausal women.

Because the chemical structure of “trig” was so unlike estradiol, Allred didn’t think the compound would be estrogenic.

“Estrogen-dependent tumors in the presence of estradiol will grow faster,” Allred said. “If you use those cells in a laboratory setting, you can determine whether something is estrogenic because they will literally make a tumor grow faster.”

He said that a series of experiences and different approaches showed that “trig,” a vitamin derivative, was fairly estrogenic at very low concentrations.

“We haven’t gotten as far as to suggest that if a woman had the disease that it would necessarily be a problem. But what we’ve proven is that the compound is estrogenic or can be at certain concentrations and doses,” Allred said.

He added that “trig” is in coffee beans, though in different amounts depending on the variety of coffee bean. The two major types of coffee beans used for what is consumed in the U.S. both contain it, he said.

“The more you roast a coffee bean, the less there is,” Allred said. “But the most critical aspect is that when you do a water extract of ground coffee, which is basically how you make a cup of coffee. It does in fact come out in the water, so we know it is in a cup of coffee.”

Nevertheless, the researchers have no idea what the exposure level would be or whether a particularly exposure ““ say from one cup of coffee ““ would be in the range seen in the laboratory tests.

“It is way too early to say that drinking a cup of coffee is exposing you to something that is definitely going to be estrogenic. All we know is that there is a compound in there that can be estrogenic in our systems. That is really the take-home message,” Allred said.

Allred also cautioned that people often narrow one compound in a food without considering the total mix of compounds and how they interact with each other or in a human body.

“There is never a single compound when you’re looking at food, and a cup of coffee is a food,” Allred said. “There’s a whole bunch of other things in it. There’s caffeine. There’s actually a little bit of fat. There are all sorts of others things in a cup of coffee that could interact with this.”

The numerous compounds in each food product means there are complex interactions, he explained, which is why nutritionists advise people that the whole food is better than any individual compound.

“That’s why you can’t take supplements to make up for food. You can never take all the things that are in a carrot and replace a carrot. In the end, you need to eat the carrot,” he said. “We’re a long way from understanding what this compound could do in the context of a food.”

He said a concern is that menopausal women seek over-the-counter phytoestrogen compounds to relieve symptoms such as hot flashes. Women want what they believe to be a natural and/or safe mechanism, he said, because hormone replacement therapy has such a negative connotation.

But, Allred said, researchers estimate that from the time an estrogen-dependent breast tumor begins until it is diagnosed in a woman is about 30 years.

“That means there will be a number of women out there who will become menopausal, and begin to take phytoestrogens in supplement form,” he said. “The majority of those come from soy. So our concern was, what if a woman becomes menopausal which means her estrogen levels are going to be low, she has estrogen-dependent breast cancer and doesn’t even know it. And now she’s consuming phytoestrogens.

“Physicians would never recommend you be on hormone replacement therapy if you had estrogen-dependent cancer. From a toxicology standpoint, it would that be a bad thing if you were consuming these phytoestrogens in high enough doses. It could be really dangerous.”

A problem is that people believe that natural or plant-derived compounds are automatically safe which is not necessarily always true, he said. Also, consuming a compound in its pure form as a supplement in high doses may not be healthy.

“If we were getting a hormone from an animal, you wouldn’t see people do that,” he said. “The only difference is that this is a plant-derived compound, so they feel it is safe when that may not be so.”

Yet, Allred added, scientists are finding that at least some of these compounds are doing positive things to prevent colon cancer.

“So there’s going to be places that it’s good ““ just as we’ve seen with estradiol,” he noted. “There are going to be some disease states that it is quite good for and some disease states that you need to be mindful of.”

Still, the compound’s potential as a weapon against colon cancer has the researchers “pretty excited about that.”

“We’re seeing very interesting information as far as tumor formation and the ability of phytoestrogens to prevent colon cancer formation. So any other new, natural phytoestrogen that we are able to identify and relate to the diet, that would be the model we’d bring it in to,” Allred said of possible future studies on “trig.”

He said a hope would be to develop a drug that could treat colon tissue without getting into the entire body, thus exploiting the compound’s mechanism to protect again cancer formation without producing other estrogenic effects.

“It’s really important for us to come up with strategies that we can have the benefits in the colon without the risks associated with (estrogenic compounds),” Allred said.

On the Net:

Nearly A Million Users Banned From Xbox Live

Thousands of gamers using Microsoft’s online gaming service Xbox Live may have had their accounts cut off by modifying their consoles to play pirated games, BBC News reported.

Microsoft confirmed that it had banned a “small percentage” of the 20 million Xbox Live users worldwide and several online reports say as many as 600,000 gamers may have been affected.

Modifying an Xbox 360 console “violates” the service’s “terms of use” and would result in a player being disconnected, according to Microsoft.

The company released a statement saying that all consumers should know that piracy is illegal and that modifying their Xbox 360 console to play pirated discs violates the Xbox Live terms of use and will void the warranty and result in a ban from Xbox Live.

“The health of the video game business depends on customers paying for the genuine products and services they receive from manufacturers, retailers, and the third parties that support them,” the statement said.

Microsoft has equipped the Xbox 360 with Digital Rights Management (DRM) technologies to detect pirated software.

However, many gamers modify their consoles by installing new chips or software that allows them to run unofficial – but not always illegal – programs and games.

But some chips are specifically designed to play pirated games.

The company did now say how it was able to determine which gamers to disconnect.

Microsoft said in a statement it does not reveal specifics, but it can say that all consoles have been verified to have violated the terms of use.

Gamers with any modifications were met with a message during the login process that read: “Your console has been banned from Xbox”.

The ban does not stop the console from working and only affects a gamer’s Xbox Live account, according to reports.

The banning is part of an annual November sweep that Microsoft carries out each year to remove modified Xboxes from its online gaming service.

So-called “modding” or “chipping” is popular among people who want to play pirated games and games bought in other regions.

On the Net:

Chinese Debate Creation Of Artificial Snow Over Beijing

Scientists in China refueled the debate over the practice of tinkering with Mother Nature by artificially inducing the second major snowstorm to wreak havoc in Beijing this season, AFP reported.

The National Meteorological Center said the earliest snow to hit the capital in 22 years fell on the first of November and the capital was again shrouded in white Tuesday with more snow expected in the coming three days.

The Beijing Weather Modification Office had artificially induced both storms by seeding clouds with chemicals, a practice that can increase precipitation by up to 20 percent, according to The China Daily, which cited an unnamed official.

On Tuesday, an official had said the storm was “natural.”

Such methods are aimed at alleviating a drought over much of north China — including Beijing — that has lingered for more than a decade, city weather officials reported.

Meanwhile, many residents of Beijing have complained about the flight delays, traffic snarls, cancelled classes and other inconveniences of a surprise snowstorm.

Most agree that officials could warn them if they are planning to toy with the clouds.

The paper reported that beyond the day-to-day hassles, experts said the weather manipulation had other undesirable side effects in the longer term.

Xiao Gang, a professor in the Institute of Atmospheric Physics at the Chinese Academy of Sciences, told the paper that no one could tell how much weather manipulation will change the sky.

“We should not depend too much on artificial measures to get rain or snow, because there are too many uncertainties up in the sky,” he said.

The more than 5,500 tons of erosive snow-melting chloride used on city roads Tuesday — nearly half the annual allotment — could erode steel structures of buildings, according to Zhao Nan, a Beijing engineer, was quoted in The China Daily.

The paper cited official statistics that showed the snow-melting agent was responsible for killing 10,000 trees in Beijing and decimating 2.15 million square feet of grassland in 2005.

State press reports said that despite a massive effort to clear the capital of snow that involved over 15,000 workers, many roads remained blocked, while highways into Beijing and in neighboring Hebei and Shanxi provinces were shut down.

On the Net:

New Nanocrystalline Diamond Probes Overcome Wear

Researchers at the McCormick School of Engineering and Applied Science at Northwestern University have developed, characterized, and modeled a new kind of probe used in atomic force microscopy (AFM), which images, measures, and manipulates matter at the nanoscale.

Using diamond, researchers made a much more durable probe than the commercially available silicon nitride probes, which are typically used in AFM to gather information from a material, but can wear down after several uses.

Horacio Espinosa, James and Nancy Farley Professor of Manufacturing and Entrepreneurship, and his graduate student Ravi Agrawal have shown that diamond atomic force microscopy probes are 10 times more durable than silicon nitride probes.

Their results were recently published in the Journal of Applied Physics.

“It is well-known that diamond should perform much better than other probe materials,” says Espinosa. “However, rigorous quantification of wear and the development of models with predictive capabilities have remained elusive. It was exciting to discover that diamond probes are an order of magnitude more wear resistant than silicon nitride probes and that a single model can predict wear for both materials.”

In the study, wear tests were performed using AFM probes made from different materials “” silicon nitride, ultrananocrystalline diamond (UNCD) and nitrogen-doped UNCD “” by scanning them across a hard UNCD substrate. Argonne National Laboratory, where UNCD was originally invented, also supported this work by providing nitrogen-doped UNCD. Probes were made in house and also provided by Advanced Diamond Technologies, Inc. (ADT).

“It took quite an effort to develop UNCD into a sharp tip. We needed to optimize the initial stages of diamond growth to form nanometer structures with consistent results. It is really nice to find that this work paid off to demonstrate that UNCD probes are quite wear resistant, which we predicted,” said Nicolaie Moldovan, a former research professor at Northwestern University involved in the fabrication of the UNCD probes. Moldovan is now a microfabrication expert at Advanced Diamond Technologies, Inc.

In addition to characterizing the probe, researchers also created a model that can predict how a probe tip will wear.

“The development of a general model with predictive capabilities is a major milestone. This effort also provided insight into how the interfacial adhesion between the probe and substrate relates to the wear resistance of AFM probes,” says Agrawal.

Neil Kane, president of ADT, said, “The results reported in this investigation are impressive in showing the improvement in wear resistance of diamond probes. This work in part inspired the development of our commercially available NaDiaProbes®.”

On the Net:

Anisakiasis Hazard Varies Depending On Origin Of The Fish

A research team of the University of Granada (Spain) has confirmed a higher presence of the parasite Anisakis spp in anchovies of the Atlantic South East coast and the Mediterranean North West coast, and they insist on freezing or cooking fish before consuming it.

Although restaurants are required by the European Union and the Spanish law to freeze the hours at -20 ºC”, say the UGR scientists, who have also detected Anisakis spp larvae and another similar parasite, the Hysterothylacium aduncum, in anchovies at the West of the Mediterranean Sea and the East of the Atlantic Ocean.

“The risk of contracting anisakiasis by ingestion of anchovies (Engraulis encrasicolus), may be influenced by the geographic area of catching, as there is a great variation in the parasites (average prevalence and intensity) of anchovies of different areas”, explains to the platform SINC Adela Valero, main author and researcher of the Department of Parasitology of the UGR.

The study, which has been recently published in the International Journal of Food Microbiology, has analyzed 792 anchovies caught between October 1998 and September 1999 in the fish market of Granada. Half of them came from the East of the Atlantic Ocean (Gulf of Cadiz and Strait of Gibraltar) and the other 396 of the West of the Mediterranean Sea (Alboran Sea, Mar Catalán, Gulf of Lion and Mar de Liguria).

According to the researchers, the parasite Hysterothylacium aduncum was more frequent in the anchovies of the Mediterranean Northeast, specifically the Gulf of Lion and the Ligurian Sea. In the anchovies caught in the Atlantic area of the Strait of Gibraltar (Gulf of Cadiz and the Strait), Anisakis is more frequent than in those coming from the Mediterranean area (Alboran Sea), “apparently due to the presence of cetaceans”, points out Valero. “This connection is especially obvious in the anchovies coming from the Ligurian Sea, where the presence of Anisakis and cetaceans is higher than in the rest of the areas studied”, says Francisco Javier Adroher, other of the authors and researcher of the UGR. This involves a higher hazard for consumers, if they do not freeze fish.

Fish muscles, habitat of the larvae

Another factor that increases the probability of infection for the parasite is the migration of the larva to the fish muscle. According to the scientists, “the higher presence of the parasite in the muscle increases the risk of contracting anisakiasis with the consumption of pickled anchovies”. The scientists of Granada have also proved that the presence of the parasite in fishes increases depending on the fish size. “As pickled anchovies are prepared with bigger ones, the risk also increases”, adds Adroher.

Valero and his team point out that more studies are required to identify the marine areas with a higher presence of parasites which can affect human health. This way it will be possible to determine if the abundance of the parasite in certain areas varies with time, “which would allow to design and apply measures to limit human exposure to such parasites”.

Image Caption: This is an Anisakis spp parasite in a hake slice. Credit: University of Granada

On the Net:

Pharmaceutical Giant Donating H1N1 Vaccines To Poor Countries

GlaxoSmithKline announced on Tuesday that they are giving 50 million doses of the swine flu vaccine to the World Health Organization, who will then give the medicines to developing countries in need.

The British pharmaceutical company has partnered with WHO and other health establishments to get the shipments of the H1N1 vaccine into the mail before December, they said in a statement.

“GSK is committed to supporting governments and health authorities around the world in their efforts to protect their populations against this pandemic,” said GSK chief executive Andrew Witty stated.

WHO director Margaret Chan added that this gift of vaccines is considered a “very generous donation.”

“This is a real gesture of global solidarity towards those who would not otherwise be able to have access to the vaccine. WHO will now work to see that these vaccines are distributed to those who need them,” she added.

GSK is also going to market the vaccine to poorer countries at a much cheaper price, the drugs company said, and is discussing with WHO about contributing their antiviral drug, Relenza, to their donation.

5,700 people have passed away around the world since the A(H1N1) virus emerged in April, says WHO statistics.

On the Net:

Can A Smartphone Diagnose Your Cough?

American and Australian scientists say they are working on a new breed of software which could turn your cell phone into a Star Trek-like device capable of diagnosing what ails you simply by coughing into the microphone.

Researchers at the research firm STAR Analytical Services say that if medical experts are able to tell whether a patient has pneumonia or just a cold, or whether an infection is viral or bacterial just by the sound of a cough, then there’s no reason why a computer program shouldn’t be able to do it as well.

And they claim that they are developing a program that can do just that, potentially saving patients and insurers millions in expensive and unnecessary trips to the hospital, while at the same time alerting seriously ill patients to their possibly hazardous health condition.

In the medical field, where diagnostic devices and treatments for specific diseases have been growing ever more high-tech in recent years, Suzanne Smith of STAR posed the question: “Why haven’t we been measuring coughs?”

“It’s the most common symptom which a patient presents, and we are relying on doctors and nurses with good old technology from the 19th century,” explained Smith.

A cough can generally be described as a defensive reflex used by the body to help clear the respiratory passage of mucous, foreign particles and microorganisms.  The anatomy of a cough consists of three phases: inhalation of air to the lungs, forced exhalation against a closed glottis, and finally a forceful release of air from the lungs following a reopening of the glottis which is accompanied by a complex burst of sounds.  On average, the whole process lasts only about quarter of a second.

Despite the basic similarity of all coughs, however, significant variations exist between coughs and are typically dependent on the kind of illness from which the patient is suffering.  A voluntary cough, for example, is usually louder and more vigorous than the involuntary coughs of a sick person.  The degree to which the vocal cords vibrate after the initial outburst of the cough sound can also give clues as to what type of irritant is present in the respiratory tract.

STAR researchers say that their software will attempt to analyze a patient’s cough by comparing it with a pre-recorded digital library of various cough sounds, all of which will be labeled and classified according to sex, age, weight and type of illness.

At the moment, company researchers say that their database consists of coughs from several dozen patients, but they estimate that they will have to use nearly 1,000 before the program can be considered reliable and accurate.

While the nascent program is currently being tested and developed on a standard computer, engineers say it will likely not be a problem to convert the software into a smartphone-friendly application.

Cough specialist Dr. Jaclyn Smith at the University of Manchester, expressed enthusiasm over the project.

“If they can find certain parameters to use coughs to diagnose disease that could be fabulous.  It could really improve disease diagnosis and help improve people’s access to health care,” Smith told Discovery News.

The Bill and Melinda Gates Foundation, the world-renowned philanthropic organization, has donated $100,000 to STAR to pursue their digital cough-detecting research, which they hope could potentially become an effective and inexpensive early diagnostic tool in third-world countries where pneumonia kills millions of children every year.

On the Net:

Researchers Find New Way To Spot Fraud

Companies that commit fraud can find innovative ways to fudge the numbers, making it hard to tell something is wrong by just looking at their financial statements. But research from North Carolina State University unveils a new warning system that sees through accounting tricks by evaluating things that are easily verifiable, such as the number of employees or the square footage that a company owns. If a company says that its profits are up, but these nonfinancial measures (NFMs) are down, that’s a sign something is probably wrong.

“Some companies commit financial statement fraud, and a good portion of those overstate their revenue,” says Dr. Joe Brazel, an assistant professor of accounting at NC State and co-author of the research. “They’re able to do that because they can manipulate the accounting. But there are NFMs that can’t be manipulated as easily.” These NFMs include the number of employees, as well as industry-specific measures, such as the square footage of facilities in the manufacturing sector, the number of retail outlets in the retail sector or the number of hospital visits in the hospital industry.

Brazel explains that companies may fraudulently claim inflated revenues in order to meet market expectations and maintain, or improve, their stock price ““ as well as protecting company management from criticism.

But, Brazel says, “when these firms commit fraud, we found a huge gap between their reported revenue growth and related NFMs ““ their revenue was up, but the NFMs were either flat or declining. And when you looked at their competitors, you see revenue growth and NFMs closely correlated. So when you see that gap, it’s a red flag ““ you need to take a closer look.”

For example, Brazel says that researchers found a difference of approximately 4 percent between revenue growth and employee growth in companies that did not commit fraud. The difference between revenue growth and employee growth in fraudulent companies was 20 percent. “It’s pretty obvious, when you look at it,” Brazel says.

Furthermore, the NFM data are easy to find. Brazel explains that each company’s NFMs and revenue numbers are disclosed in the same financial filings, which the company is required to submit each year to the U.S. Securities and Exchange Commission.

The researchers evaluated 220 companies when evaluating employee growth versus revenue growth ““ 110 companies that were known to have committed fraud between 1994 and 2002, and 110 that had not. Similarly, they looked at 100 companies when evaluating other NFMs, 50 fraudulent and 50 that had not committed fraud.

The researchers are now in the process of developing an online tool that will perform the NFM analysis, as well as conducting experimental studies with auditors to help detect fraud and with investors to help make wise investment decisions.

The paper, “Using Nonfinancial Measures to Assess Fraud Risk,” was co-authored by Brazel, Dr. Keith Jones of George Mason University and Dr. Mark Zimbelman of Brigham Young University. The work was funded by the Institute of Internal Auditors Research Foundation and the Financial Industry Regulatory Authority Investor Education Foundation, and will be published in the Journal of Accounting Research later this year.

On the Net:

H1N1 Deaths Exceed 6,000 – Animals Affected As Well

More than 199 countries and overseas territories have reported lab-confirmed cases of A(H1N1) influenza as of November 1, resulting in more than 6000 deaths, according to figures released Friday by the World Health Organization (WHO).

“As many countries have stopped counting individual cases, particularly of milder illness, the case count is likely to be significantly lower than the actual number of cases that have occurred,” said the WHO in its weekly update of the A(H1N1) influenza outbreak.

The pandemic is currently being driven by broad transmission throughout North America, coupled with an early start to winter flu season in Europe and parts of Asia, the U.N. health agency said.

“Intense and persistent influenza transmission continues to be reported in North America without evidence of a peak in activity,” the WHO said.

“Significantly more cases of pandemic H1N1 have been recorded in Mexico since September than were observed during the initial springtime epidemic,” the UN body said in its weekly update.

As of November 1, the official global death toll from A (H1N1) stood at 6,071, the WHO said.  Of those, 4,399 deaths, or nearly three-quarters, occurred in the Americas region — an increase of 224 in just one week.

There are also signs of “increasing and active transmission” of pandemic flu virus across Northern and Eastern Europe, including Ukraine and Belarus and eastern Russia, the WHO said.

The pandemic is also gaining strength in Mongolia, Oman, Afghanistan and Japan, but is waning in tropical areas of Central and South America and parts of south Asia.

The WHO also called on Friday for stricter monitoring of farm workers and animals for influenza A viruses, following a string of recent cases in a wider range of animals than pigs.

Although these cases were isolated and did not impact how the A(H1N1) pandemic evolved in humans, recent findings may indicate broader potential for flu viruses to mix and mutate, the WHO said.

“While most influenza A viruses circulating in mammals preferentially infect a single species, cross-species transmission is known to occur,” said the WHO in a briefing note.

Pigs have historically acted as “mixing vessels” for different types of flu viruses, allowing them to mutate into new forms that could be transmitted to humans.

“These recent findings further suggest that influenza A viruses in animals and humans increasingly behave like a pool of genes circulating among multiple hosts, and that the potential exists for novel influenza viruses to be generated in animals other than swine,” said the WHO.

“This situation reinforces the need for close monitoring and close collaboration between public health and veterinary authorities,” it added.

“When influenza infections are detected in farmed animals, WHO recommends monitoring of farm workers for signs of respiratory illness, and testing for H1N1 infection should such signs appear.”

Currently, nations are only required to notify international authorities of avian influenza cases, although some nations have additional domestic rules that apply to other animals, such as pigs.

However, since the rules also require reporting of “any emerging disease” in animals to the World Animal Health Organization (OIE), “this would include infections with the pandemic H1N1 virus or other novel influenza viruses,” the WHO said.

The agency stressed that lab tests had not detected signs that the virus had mutated to a more virulent form.

“These isolated events have had no impact on the dynamics of the pandemic, which is spreading readily via human-to-human transmission,” it said.

The recent cases involving animals have included swine flu in pigs.

“As human infections become increasingly widespread, transmission of the virus from humans to swine is likely to occur with greater frequency,” the Geneva-based health agency added.

Other A(H1N1) infections have been reported in turkeys in Chile and Canada, and in domestic pets, including a cat in the United States. The UN health agency also noted the progress of highly virulent H5N1 bird flu in recent years. 

Another case involved a “novel H3N2 influenza virus” recently found in mink in Denmark.  The virus is a combination of human and swine genes that had not been previously identified in circulating flu viruses, the WHO said.  However, testing of workers at the mink farms detected no spread to humans.

“However, the incident demonstrates the constantly evolving ecology of influenza viruses, the potential for surprising changes, and the need for constant vigilance, also in animals,” the WHO said.

The AFP news agency cited the Paris-based OIE as saying on Wednesday that there was no evidence that animals had played “any particular role in the epidemiology or the spread” of the pandemic virus.

“It does not come as a surprise that notifications of infection in new animals species are received; on the contrary it demonstrates animal disease surveillance is efficient and functioning to the benefit of all,” said OIE Director General Bernard Vallat in a statement.

As the pandemic continues to spread throughout the United States, many are having trouble gaining access to the swine flu vaccine.

A new telephone poll conducted by the Harvard School of Public Health found than just one-in-three adults who have attempted to get a swine flu vaccine have been able to do so. The figures held true even among those at heightened risk for severe complications and among parents who had tried to obtain the vaccine for their high-risk children.

The vaccine has been available in the U.S. for about a month, but supplies have been limited due to  manufacturing delays.

At this point, the shots are only supposed to be given to those at high risk of complications.

The Harvard poll, which surveyed 1,000 adults last weekend, also showed that half of those who tried could not find information about where to obtain the swine flu vaccine.

Swine flu is widespread in 48 states, according to comments made Friday by officials with the Centers for Disease Control and Prevention (CDC).  Many millions of Americans have been infected with the virus, though most suffered only mild illness.  CDC officials said that 129 children have died from swine flu complications since April, when the virus was first identified.  

The WHO’s full November 6 weekly update can be viewed at http://www.who.int/csr/don/2009_11_06/en/index.html.

New Finding Suggests Prostate Biopsy Is Not Always Necessary

Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy.

Elevated levels of PSA have traditionally been seen as a potential sign of prostate cancer, leading to the widespread use of PSA testing. However, the researchers found that parathyroid hormone, a substance the body produces to regulate calcium in the blood, can elevate prostate-specific antigen (PSA) levels in healthy men who do not have prostate cancer. These “non-cancer” elevations in PSA could cause many men to be biopsied unnecessarily, which often leads to unnecessary treatment.

“PSA picks up any prostate activity, not just cancer,” said lead investigator Gary G. Schwartz, Ph.D., M.P.H., an associate professor of cancer biology and epidemiology and prevention at the School of Medicine. “Inflammation and other factors can elevate PSA levels. If the levels are elevated, the man is usually sent for a biopsy. The problem is that, as men age, they often develop microscopic cancers in the prostate that are clinically insignificant. If it weren’t for the biopsy, these clinically insignificant cancers, which would never develop into fatal prostate cancer, would never be seen.”

However, because PSA screening has become so common, more men are being biopsied, Schwartz said. Most men, when told that they have prostate cancer, elect treatment even though it may not be necessary. In reality, Schwartz said, in only one of six cases does a biopsy diagnosis of prostate cancer result in a cancer that would be fatal if untreated.

High rates of prostate biopsy, therefore, lead to the over treatment of prostate cancer, he said, leading to an increased rate of the side effects of treatment, including impotence and urinary incontinence.

The study, coauthored by Halcyon G. Skinner, Ph.D., M.P.H., of the University of Wisconsin-Madison, appears in the current issue of Cancer Epidemiology, Biomarkers & Prevention.

For the study, the researchers analyzed data from 1,273 men who participated in the National Health and Nutrition Examination Survey 2005-2006, and who did not report any current infection or inflammation of the prostate gland, prostate biopsy in the past month, or history of prostate cancer at the time of the survey.

After adjusting for age, race and obesity ““ because PSA levels increase with age, are higher in black men, and are lower in overweight men ““ the researchers found that the higher the level of parathyroid hormone in the blood, the higher the PSA level. In men whose parathyroid level was at the high end of normal, the PSA level was increased by 43 percent ““ putting many in the range for the urologist to recommend a biopsy.

The finding is especially significant for black men, added Skinner. About 20 percent of black men have elevated parathyroid hormone levels, compared with about 10 percent of white men ““ which means blacks have a greater chance of being recommended for biopsy and over treated, he said.

This finding “could help scientists refine the prostate cancer screening test to better differentiate between those men who need to be biopsied and those who might be spared the procedure,” Schwartz said. “It’s likely that there are a lot of men out there with elevated PSAs that may be due to elevated parathyroid hormone rather than prostate cancer.”

Parathyroid hormone is made by cells of the parathyroid glands, four small glands embedded in the thyroid. Although parathyroid hormone primarily controls calcium levels in the blood, recent research has shown that parathyroid hormone can promote prostate cancer cell growth. The research by Schwartz and Skinner is the first to suggest that parathyroid hormone also promotes prostate cell growth in men without prostate cancer.

On the Net:

2 Children With Adrenoleukodystrophy Saved Thanks To ELA Association

The ELA Association represents the largest funder for research on this fatal brain disease

The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regarding the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.

Gene therapy on adrenoleukodystrophy: a world premiere

Adrenoleukodystrophy (ALD) is the most frequent form of leukodystrophies. It affects nearly 30 % of leukodystrophy cases identified by the ELA association. Each year, 35 babies with adrenoleukodystrophy are born in France, but death often occurs during childhood.

Until now, the treatment for ALD relied on bone marrow transplant, an approach which is limited by the scarcity of donors and the risk of serious complications. With this new approach, physicians have chosen to perform an autologous graft combined with gene therapy. For this procedure, the bone marrow stem cells of the patients are harvested, and then corrected in the laboratory before being transplanted back into the patients. Some of these cells will naturally find their way to the patient’s brain where they will display their correcting potential. Another innovation: a vector derived from a modified and inactivated HIV virus was used to insert the correct gene into bone marrow cells. HIV represents the only virus able to introduce a therapeutic gene into the nucleus of non-dividing cells, like stem cells and neurons, in order to allow a long-term effect of this gene.

With 7 million Euros invested, ELA is the largest funder for research on ALD

These very large amounts of money have been gathered thanks to the actions undertaken by millions of school children, to the support of the French Ministry of Research, to the generosity of all the donors. Also, the involvement of our partners and ambassadors, led by Zinedine Zidane and Florent Pagny, contribute to this success.

A discovery that will benefit to widespread diseases

Today, ELA is even prouder of this result because this innovative approach opens up treatment perspectives for other types of leukodystrophies and most importantly to other widespread diseases (sickle cell anemia, beta-thalassemia and multiple immunodeficiencies, hemophilia, Parkinson’s disease, “¦) which could benefit from a similar gene therapy treatment using a HIV-derived vector.

Founded in 1992 by Guy Alba, parent of a child with ALD, with the encouragement of Pr. Aubourg, chairman of the scientific committee until 2008, ELA brings together European families affected by leukodystrophies, a group of genetic diseases that destroy the myelin (nerve sheath) in the brain. Since its creation, ELA pursues the same goals: support patients, gather families and fund medical research. To accelerate the discovery of a treatment, ELA founded its own research foundation in 2005 with the support of the French Ministry of Research. The foundation’s efforts and momentum permitted dedicating 30 million Euros for all kind of leukodystrophies.

Concomitantly, ELA cares for patients and brings special attention to those who may not benefit from research advances. That’s why ELA commits 4.3 million Euros for the support of patients and their families needs. With the same motivations, ELA supports the development of similar organizations in Europe (Belgium, Spain, France, Italy, Luxembourg, and Switzerland).

And ELA is planning for more

1. extend the trial in Europe and recruit new patients including adults

2. develop a newborn screening test

3. offer the therapy to all ALD patients

Testimony of Guy Alba, founder and president of the ELA association (ELA) and parent of a child suffering from adrenoleukodystrophy (ALD)

I met Pr. Patrick Aubourg for the first time in 1991, when he diagnosed my 5 year-old son with adrenoleukodystrophy. I knew precisely the damages caused by this horrible disease (loss of motor function, of vision, speech, hearing, memory…) because they were destroying my nephew, 5 years older than my son, prefiguring what will happen to my little boy.

Although petrified by this astounding news, it seemed nevertheless inconceivable to passively wait for the worst to come. I had long conversations with Patrick Aubourg who encouraged me to create a patient organization and accepted to chair its scientific committee. This is how ELA was born in 1992.

17 years later, the present victory over adrenoleukodystrophy bears the marks of all these fighting years, pains, losses, but also of numerous moments of solidarity and happiness. This victory against the disease is due first and foremost to the great research team lead by Pr. Patrick Aubourg and Dr. Nathalie Cartier. We also owe this victory to the tenacity of the highly committed ELA families who held on during all this time. We are furthermore indebted to the thousands of school children involved each year for ELA, to all our donors, all our partners, and if there was only a single one to name, to Zinedine Zidane, given his personal level of involvement and care.

Thanks to him and to them, ELA was able to fund ALD research at both national and European levels, but in the US as well, globally in a quite exceptional manner (7 million Euros invested so far), and to continuously support Pr. Aubourg’s team since 1992.

All ELA families were impatiently waiting for this major breakthrough even those who do not expect anything from this discovery because the disease has already taken everything away from them. Today we are even prouder of this result because gene therapy on ALD opens up treatment perspectives for numerous other diseases that are more widespread. The children of ELA have thereby contributed to open the way for a new therapy which, we truly hope, will be useful to many other sick children and adults suffering from many kinds of diseases. It will be our best reward.

On the Net:

Bacterium Help Cockroaches Store Excess Uric Acid

Finding could lead to new understanding of substance harmful in kidney disease and other human diseases

What life form can use materials as nutrients that we, and most other animals, would consider waste products?

None other than the giant cockroaches that infest sewer systems and erupt from people’s bathtub drains, according to scientists Nancy Moran and Zakee Sabree of the University of Arizona, and Srinivas Kambhampati of Kansas State University.

The researchers published their results in last week’s issue of the journal Proceedings of the National Academy of Sciences (PNAS).

Uric acid and urea are nitrogenous waste products not useful to animals as food. But by teaming up with a bacterium, cockroaches can use them as sources for making their own proteins.

“It’s an example of a symbiosis,” says Moran, “that allows a whole new way of life.”

One day, it might help us better understand how animals successfully store excess uric acid, a problem in human kidney disease and other diseases.

Insects are the most abundant and diverse animals on Earth, says Matt Kane, program director in the National Science Foundation (NSF)’s division of environmental biology, which funded the research.

“Through genome sequencing like that used in this study,” says Kane, “we’re increasingly finding that this success can be attributed to the relationships insects have forged with microorganisms.”

Cockroaches are one of the most widely recognized insects. “While the common response to the mention of these creatures is revulsion,” says Moran, “their maligned reputation is largely due to the actions of a few cockroach species.”

Fewer than one percent of known cockroaches has any association with humans.

The American cockroach (Periplaneta americana), however, is a common pest that happily resides in the shadows of human life.

Like many cockroaches, P. americana is primarily herbivorous and feeds on decaying plant matter. But it can also be an opportunistic carnivore that feeds on dead animals and animal wastes.

“Having enough nitrogen in their diets is a primary requirement for cockroaches,” says Moran. “While many insects excrete waste nitrogen in the form of uric acid, instead cockroaches internally store it that way.”

Cockroaches can take advantage of nitrogen windfalls by stockpiling nitrogen in uric acid, then drawing upon these reserves when other sources of nitrogen are lacking.

The scientists observed uric acid stored in cockroaches’ bodies. A bacterial endosymbiont, or partner, was also seen residing within specialized cells, called bacteriocytes, in the cockroaches.

Named Blattabacterium, this bacterial endosymbiont was observed not only in the American cockroach, but in various other cockroach species.

“We estimate that it’s been associated with cockroaches for more than 140 million years,” says Sabree.

“Its role is likely two-fold: providing nutrients and, given its close proximity to uric acids in the host insect’s bodies, degradation of uric acid so levels don’t get too high and kill the cockroaches.”

Moran, Sabree and colleagues sequenced the genome of the P. americana-associated Blattabacterium species, hoping to better understand the nature of this insect-bacterial relationship. They found that the bacterium is capable of producing all essential amino acids, many non-essential amino acids, and various vitamins.

Surprisingly, no genes known to encode enzymes involved in degradation of uric acid were found in the bacterium’s genome, but it can use urea and ammonia, both uric acid degradation products, to generate nutrients.

Blattabacterium can recycle waste nitrogen, “but it’s still unclear what exact role it plays in degrading uric acid,” says Moran.

“However,” she says, “for eons, it likely has allowed cockroaches to subsist on nitrogen-poor diets and to exploit nitrogenous wastes, capabilities that are critical to the ecological range and global distribution of cockroach species.”

By Cheryl Dybas, NSF

Image 1: The American cockroach may point the way to a new understanding of uric acid metabolism. Credit: Zakee Sabree

Image 2: A microscope photograph shows the bacterium in cockroaches that helps them store uric acid. Credit: Zakee Sabree

On the Net:

Microsurgery Technique For Breast Reconstruction, Tummy Tuck After Mastectomy

Since her teens, Jennifer Jablon had watched family members deal with breast cancer during their 40s, 50s, and 60s. She wondered whether it would be her fate too.

In her mid-50s, Jennifer’s mother was diagnosed with breast cancer and tested positive for the recently identified BRCA1 gene, indicating a genetic predisposition to breast cancer.

“I spent about six months in denial after my mom tested positive. When I finally tested myself, I tested positive for the gene,” she recalled. During subsequent MRIs, doctors twice found benign cysts, prompting her to seek a prophylactic bilateral mastectomy “” a precautionary procedure in which both breasts are removed to minimize the risk of malignancy.

The choice also set her thinking about breast reconstruction options.

The 36-year-old mother of a 7-year-old opted for a relatively new and rare microsurgery by plastic surgeons at UT Southwestern Medical Center called the Deep Inferior Epigastric Perforator (DIEP) flap procedure.

“The DIEP flap procedure can offer women seeking breast reconstruction after a mastectomy some of the advantages of a more natural breast with the effects of a tummy tuck. Although it is more complex surgery, it preserves muscles for quicker recovery and less postoperative pain,” explained Dr. Michel Saint-Cyr, assistant professor of plastic surgery and one of the few surgeons in the nation trained to perform the procedure.

In the DIEP flap procedure, surgeons reconstruct the breast with skin and fat taken from the abdomen. They then individually reattach blood vessels to the relocated tissue under a microscope in a technically challenging procedure.

The procedure can be done immediately after a mastectomy, so patients can have breast tissue removed yet awaken with reconstructed breasts, Dr. Saint-Cyr said.

“The goal was to go to sleep with two and wake up with two,” said Ms. Jablon, who underwent the procedure this past spring.

In addition, for many women, the reconstructed breast is firmer, has a more youthful appearance than prior to reconstructive surgery and ages similarly to a natural breast, said Dr. Saint-Cyr, who specializes in breast reconstruction surgery.

To determine whether DIEP flap or other reconstruction options are suitable, Dr. Saint-Cyr recommends that women consult with a board-certified plastic surgeon who has experience with all the available procedures.

“This is a critical life decision, so all options should be on the table. That may not necessarily happen if the physician doesn’t have experience in all these procedures,” said Dr. Saint-Cyr, who has written numerous papers on the DIEP flap and similar procedures for peer-reviewed journals.

“Due to the complexity of the microsurgery, only about 40 surgeons nationwide routinely perform these types of procedures, so travel may be required for some women to find a surgeon with the needed experience,” Dr. Saint-Cyr said.

Procedures such as those used for Ms. Jablon will be discussed Dec. 5 at a seminar hosted by UT Southwestern on “What’s New in Breast Reconstruction: Optimizing Results Using a Multidisciplinary Approach.” at the Excellence in Education Auditorium in the Simmons Biomedical Research Building, 6000 Harry Hines Blvd., Dallas. Topics at the event, which is open to the public, will include options in breast reconstruction, breast conservation therapy and nipple-sparing mastectomy, and a husband and wife’s perspective after breast reconstruction. For more information or to register for the “What’s New In Breast Reconstruction seminar, call 214-648-3138, visit www.utsouthwestern.edu/courses or e-mail [email protected].

Visit www.utsouthwestern.org/plasticsurgery to learn more about UT Southwestern’s clinical services in plastic surgery.

Are The Alps Growing Or Shrinking?

Correlation between mountain growth and climate

The Alps are growing just as quickly in height, as they are shrinking. This paradoxical result could be proven by a group of German and Swiss geoscientists. Due to glaciers and rivers about exactly the same amount of material is eroded from the Alp slopes as is regenerated from the deep Earth’s crust. The climatic cycles of the glacial period in Europe over the past 2.5 million years have accelerated this erosion process. In the latest volume of the science magazine “Tectonophysics” ( No. 474, S.236-249) the scientists prove that today’s uplifting of the Alps is driven by these strong climatic variations.

The formation of the Alps through the collision of the two continents Africa and Europe began about approximately 55 million years ago. This led to the upthrusting of the highest European mountains, which probably already achieved its greatest height some millions of years ago. At present, however, the Swiss Alps are no longer growing as a result of this tectonic process.

Swiss geodesists, who have already been measuring the Alps with highest accuracy for decades, have observed, however, that the Alp summits, as compared to low land, rise up to one millimeter per year. Over millions of years a considerable height would have to result. But why then are the Alps not as high as the Himalayas? Researchers from the GFZ German Research Centre for Geosciences were able to calculate that mountains eroded concurrently at almost exactly the same speed.

“This mountain erosion cannot even be determined using the highly precise methods of modern geodesy” explains Professor Friedhelm v. Blanckenburg from the GFZ. “We use the rare isotope Beryllium-10, which develops in the land surface via cosmic radiation. The quicker a surface erodes, the fewer isotopes of this type are present therein”. Therefore, von Blanckenburg, and the GFZ geoscientist, Dr. Hella Wittmann, have analyzed this “cosmogenic” isotope in the sand of the Swiss Alps rivers and, thus, in the direct products of erosion.

How does it come about now that the Alps erode at the same speed that they rise? “Here pure upthrusting forces are at work. It is similar to an iceberg in the sea. If the top melts, the iceberg surfaces out of the water by almost the same share” explains von Blanckenburg. Thus this paradoxical situation with the Alps that through wind, water, glaciers and rock fall, they are being constantly finely eroded from the top but on the other hand, regenerated from the Earth’s mantle. This phenomenon, even if already postulated theoretically has now been proven for a complete mountain range for the first time.

Thus, the Alps are constantly rising, although they have been deemed “dead” in a tectonic sense. Instead of plate forces it is the strong climatic variations since the beginning of the so-called quaternary glacial before approximately 2.5 million years, to which mountain slopes in particular have been reacting so sensitively. This holds the Alps in motion.

Image 1: The high sediment load of the river shows the effect of the erosion at the Bernina Glacier in Switzerland. © GFZ

Image 2: Concept of the cosmic rays and nuclide production (Background: Forno glacier in Switzerland). © GFZ

On the Net:

Time Between Treatment And PSA Recurrence Predicts Death From Prostate Cancer

Men whose prostate specific antigen (PSA) rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by Fox Chase Cancer Center radiation oncologist Mark K. Buyyounouski, M.D., M.S. and presented today at the annual meeting of the American Society for Radiation Oncology (ASTRO).

“PSA is the gold standard for following prostate cancer patients after they receive radiation or surgery. But we haven’t know if having PSA rise sooner means a patient has a greater danger of dying of prostate cancer, though it seems logical,” Buyyounouski says.

Using a single institution database, Buyyounouski and colleagues showed previously that men who suffered an early biochemical failure, which is defined as their lowest PSA level plus 2 ng/mL, were at greater risk of dying of prostate cancer. The new study confirms those results using a multinational database and shows that the measure is ready for use in the clinic.

“Now we can use the simple criteria from this study, which is widely available for anyone who has PSA testing, to identify men who have a greater than 25% chance of dying from prostate cancer in the next five years. That is huge. There is nothing else that can do that,” says Buyyounouski.

A total of 2,132 men with clinically localized prostate cancer who suffered biochemical failure after treatment were studied. The median interval between treatment and biochemical failure was 35.2 months for the entire study group. However, 19% of patients developed biochemical failure at 18 months or less. The five-year cancer-specific survival for these men was 69.5% compared with 89.8% for men who developed biochemical failure after 18 months.

A multivariate analysis showed that the interval to biochemical failure correlated with cancer specific survival, as did Gleason score, tumor stage, age, and PSA doubling time. However, the interval to biochemical failure had the best predictive value for cancer-specific mortality, compared with the other variables.

Currently, most physicians do not start treatment based on biochemical failure alone, but rather wait until the PSA reaches a high level or there is some other evidence tumor spread. “The potential impact of this finding is that patients can initiate treatment far sooner without waiting for other signs or symptoms of prostate cancer,” Buyyounouski says. “If a patient has biochemical failure at 16 months, rather than wait and learn later that the PSA is rising sharply and risk the development of distant metastasis, therapy can be started sooner based on the increased risk of death.”

On the Net:

Tackling New Arctic Challenges From Space

International scientists, researchers and decision makers met at the “ËœSpace and the Arctic workshop’ to identify the needs and challenges of working and living in the rapidly changing Arctic and to explore how space-based services can help to meet those needs.

The workshop, held from 20 to 21 October in Stockholm, Sweden, was organized by the Swedish National Space Board and the Swedish Meteorological and Hydrological Institute together with ESA, EUMETSAT and the EC.

The warmer climate, advances in technology and demand for natural resources are leading to increased human activity in the Arctic. This increase in activity, especially related to oil and gas production, changing fishery patterns and new shipping routes, provides new opportunities but also creates new risks to those working and living in the area and to the pristine and unique natural environment.

One of the highlights of the workshop was the ‘Arctic Marine Transport and Space’ presentation given by Dr Lawson Brigham of the University of Alaska Fairbanks that outlined the Arctic Marine Shipping Assessment (AMSA) report for 2009.

The AMSA report, prepared by the Protection of the Arctic Marine Environment (PAME) Working Group on behalf of the Arctic Council, is designed to educate and inform people about the current state of Arctic marine use and future challenges. It focuses primarily on Arctic marine safety and marine environmental protection.

“New space assets are crucial for improving marine communications in many regions of the Arctic Ocean in order to improve search and rescue and environmental response activities,” Brigham said. “One key AMSA recommendation is the need for a comprehensive Arctic marine traffic awareness system; only space assets in the long-term can provide the coverage necessary to achieve effective monitoring and tracking of Arctic ships.”

“Improved space sensors measuring sea-ice thickness, mapping snow cover and tracking icebergs will be increasingly important to Arctic ship safety and route optimization,” he continued. “Continued satellite monitoring is also central to recording the retreat of sea ice and other changes to the cryosphere in a warming Arctic.”

In order to build the infrastructure needed in the Arctic to meet these challenges, workshop participants investigated ways space infrastructure could facilitate communication, environmental monitoring, early warning systems and navigation and vessel tracking in the area.

The workshop was held under the auspices of the Swedish Presidency of the Council of the EU as part of a commitment to face the challenges of climate change and increased human activity. It focused on these main themes: climate change & environment; transport safety and security; and sustainable exploitation.

The contributions from ongoing activities in European projects such as MyOcean, Polar View and Damocles, were presented to show how lessons learned in setting up operational services for the Baltic area could be applied in a new setting with similar information requirements for the Arctic.

After presenting their experiences in the region, participants provided suggestions as to how operational space-based services could monitor and help adapt to climate change and ecosystem management, maintain safe transportation and ensure sustainable development in the vulnerable Arctic.

At the end of the workshop, participants agreed a set of conclusions and recommendations as to how space technology could help Europe meet its objectives in the Arctic.

ESA’s ice mission, CryoSat, is scheduled to launch in February next year. CryoSat will monitor precise changes in the thickness of polar ice sheets and floating sea ice. The observations made over its three-year lifetime will help explain the connection between the melting of the polar ice and the rise in sea levels and how this is contributing to climate change.

On the Net:

Animals Contract H1N1 Virus, US Officials Confirm

The U.S. Department of Agriculture announced on Wednesday that a commercial swine herd in Indiana tested positive for the swine flu, which is the first time the virus has been detected in US pigs.

The USDA said there were four tissue samples that had traces of the virus. They added that the pigs and the people watching over the animals are in good health again.

In October, tests established that some show pigs at the Minnesota State Fair came down with the swine flu, or the H1N1 virus.

USDA officials have emphasized frequently that occurrences of pigs with swine flu are rare and do not pose a danger to pork product consumers.

However, word of a pig herd with the H1N1 virus is a blow to the pork industry, which has been plagued with poor prices due to swine flu concerns.

However, Agriculture specialists have long anticipated that the swine flu would finally find its way to domestic pigs. A hog vaccine is being created but is not yet on the market. The H1N1 strain has made an appearance in hog herds in other countries, like Canada, Australia, Argentina, Ireland, the United Kingdom and Norway.

Pigs are not the only animal that has been infected with the virus. A 13-year-old cat has a confirmed case of the swine flu, the first confirmed case of the virus present in a feline.

The cat was cared for last week at the Iowa State University College of Veterinary Medicine in Ames and is healthy again. The virus also has appeared in an Oregon and a Nebraska ferret, but they did not survive.

“We’ve known certainly it’s possible this could happen,” Centers for Disease Control and Prevention spokesman Tom Skinner said to Yahoo News. “This may be the first instance where we have documentation that transmission occurred involving cats or dogs.”

The cat’s veterinarian, Dr. Brett Sponseller, said the feline contracted the virus from its owners. The case was established at the Iowa State and the U.S. Department of Agriculture.

Other flu strains can cross species, but Sponseller warned against panicking over whether pets could contract the virus from humans.

“It’s well documented in influenza in general, but this is the first highly suspected case of H1N1 going from humans into a cat,” he said.

Dr. Ann Garvey, Iowa’s state health veterinarian, said scientists do not know how cats or other pets could contract the virus from humans.

“Because we haven’t seen that many cases, it’s difficult to give a blanket assessment on how sick it can make an animal,” she said.

Officials also emphasized that there is no proof that the flu can be sent from pets to their owners.

“But it’s so early in the game we don’t know how it’s going to behave. But that doesn’t appear to be the concern. There’s no sense of them passing it on to people,” said Michael San Filippo, spokesman for the American Veterinary Medical Association, to Yahoo News.

On the Net:

Leeches As Medicine Becoming A Booming Business

As the use of leeches in a variety of medical therapies is beginning to increase in popularity, an institution in Russia is hoping to cash in.

The International Medical Leech Center in Udelnaya refers to itself as the world’s largest leech-growing facility.

Many experts and leading institutions have begun approving the use of leeches for medical procedures.

Earlier this year, the American Journal of Nursing confirmed a resurgence of leech therapy, primarily among patients who underwent plastic and reconstructive surgery.

In 2004, the US government approved the use of leeches for medical purposes.

Actress Demi Moore announced last year that she had undergone leech therapy in Austria in an effort to detoxify her blood.

“Now this is a scientifically proven form of healing,” Gennady Nikonov, director of the International Medical Leech Center, told AFP.

“The leech is revealing more and more of its secrets to us,” Nikonov said.

Nikonov’s center is filled with glass jars containing leeches that are being grown for medical purposes.

After the collapse of the Soviet Union in 1991, the center had trouble paying employees, and Nikonov told AFP that “the building was falling apart.”

But the use of leeches for medical purposes has since seen a resurgence, which has helped the center increase production tenfold since the Soviet Union collapse.

“Leech cosmetics, unlike the ordinary kind, heal the skin from within instead of just plastering over it,” said Yelena Titova, lab director at the center.

“Here you have a whole factory of medicines, more than 30 components, and all created by nature,” Titova said.

On the Net:

New Study Warns That Climate Change Could Create Agricultural Winners And Losers In East Africa

While predicting highly variable impacts on agriculture by 2050, experts show that with adequate investment the region can still achieve food security for all

As African leaders prepare to present an ambitious proposal to industrialized countries for coping with climate change in the part of the world that is most vulnerable to its impacts, a new study points to where and how some of this money should be spent. Published in the peer-reviewed journal Agricultural Systems, the study projects that climate change will have highly variable impacts on East Africa’s vital maize and bean harvests over the next two to four decades, presenting growers and livestock keepers with both threats and opportunities.

Previous estimates by the study’s authors projected moderate declines in the production of staple foods by 2050 for the region as a whole but also suggested that the overall picture disguises large differences within and between countries. The new findings provide a more detailed picture than before of variable climate change impacts in East Africa, assessing them according to broadly defined agricultural areas.

“Even though these types of projections involve much uncertainty, they leave no room for complacency about East Africa’s food security in the coming decades,” said the lead author of the new study, Philip Thornton of the International Livestock Research Institute (ILRI), which is supported by the Consultative Group on International Agricultural Research (CGIAR). “Countries need to act boldly if they’re to seize opportunities for intensified farming in favored locations, while cushioning the blow that will fall on rural people in more vulnerable areas.”

The researchers simulated likely shifts in cropping, using a combination of two climate change models and two scenarios for greenhouse gas emissions, together with state-of-the-art models for maize and beans, two of the region’s primary staple foods.

In the mixed crop-livestock systems of the tropical highlands, the study shows that rising temperatures may actually favor food crops, helping boost output of maize by about half in highland “breadbasket” areas of Kenya and beans to much the same degree in similar parts of Tanzania. Meanwhile, harvests of maize and beans could decrease in some of the more humid areas, under the climate scenarios used in the study. Across the entire region, production of both crops is projected to decline significantly in drylands, particularly in Tanzania.

“The emerging scenario of climate-change winners and losers is not inevitable,” said ILRI director general Carlos Ser©. “Despite an expected three-fold increase in food demand by 2050, East Africa can still deliver food security for all through a smart approach that carefully matches policies and technologies to the needs and opportunities of particular farming areas.”

At the Seventh World Forum on Sustainable Development, held recently in Ouagadougou, Burkina Faso, African leaders announced a plan to ask the industrialized world to pay developing countries US$67 billion a year as part of the continent’s common negotiating position for December’s climate talks in Copenhagen.

The ILRI study analyzes various means by which governments and rural households can respond to climate change impacts at different locations. In Kenya, for example, the authors suggest that shifting bean production more to the cooler highland areas might offset some of the losses expected in other systems.

Similarly, Tanzania and Uganda could compensate for projected deficits in both maize and beans through increased regional trade. In the Common Market for Eastern and Southern Africa (COMESA), maize trade is already worth more than US$1 billion, but only 10 percent of it occurs within the region. As grain prices continue to rise in global markets, several East African countries will be well positioned to expand output of maize and beans for regional markets, thus reducing reliance on imports and boosting rural incomes.

Where crop yields are expected to decline only moderately because of climate change, past experience suggests that rural households can respond effectively by adopting new technologies to intensify crop and livestock production, many of which are being developed by various CGIAR-supported centers and their national partners.

Drought-tolerant maize varieties, for example, have the potential to generate benefits for farmers estimated at $863 million or more in 13 African countries over the next 6 years, according to a new study carried out by the International Maize and Wheat Improvement Center (CIMMYT) and International Institute of Tropical Agriculture (IITA). Meanwhile, new heat-tolerant varieties of productive climbing beans, which are traditionally grown in highlands, are permitting their adoption at lower elevations, where they yield more than twice as much grain as the bush-type beans grown currently, according to Robin Buruchara of the International Center for Tropical Agriculture (CIAT).

In areas that face drastic reductions in maize and bean yields, farmers may need to resort to more radical options, such as changing the types of crops they grow (replacing maize, for example, with sorghum or millet), keeping more livestock or abandoning crops altogether to embrace new alternatives, such as the provision of environmental services, including carbon sequestration.

This latter option could become a reality under COMESA’s Africa Biocarbon Initiative, which is designed to tap the huge potential of the region’s diverse farmlands and other rural landscapes ““ ranging from dry grasslands to humid tropical forests ““ for storing millions of tons of carbon. The initiative offers African negotiators an appealing option in their efforts to influence a future climate change agreement.

“If included in emissions payment schemes, this initiative could create new sources of income for African farmers and enhance their resilience to climate change,” said Peter Akong Minang, global coordinator of the Alternatives to Slash-and-Burn (ASB) Programme at the World Agroforestry Centre. “Its broad landscape approach would open the door for many African countries to actively participate in ““ and benefit from ““ global carbon markets.”

“Rural people manage their livelihoods and land in an integrated way that encompasses many activities,” said Bruce Campbell, director of the CGIAR’s Challenge Program on Climate Change, Agriculture and Food Security. “That’s why they need integrated options to cope with climate change, consisting of diverse innovations, such as drought-tolerant crops, better management of livestock, provision of environmental services and so forth.”

How rapidly and successfully East African nations and rural households can take advantage of such measures will depend on aggressive new investments in agriculture, CGIAR researchers argue. According to a recent study by the International Food Policy Research Institute (IFPRI), it will take about $7 billion annually, invested mainly in rural roads, better water management and increased agricultural research, to avert the dire implications of climate change for child nutrition worldwide.

About 40 percent of that investment would address the needs of sub-Saharan Africa, where modest reductions projected for maize yields in the region as a whole are expected to translate into a dramatic rise in the number of malnourished children by 2050. Thornton’s projections probably underestimate the impacts on crop production, because they reflect increasing temperatures and rainfall changes only and not greater variability in the weather and growing pressure from stresses like drought and insect pests.

“Farmers and pastoralists in East Africa have a long history of dealing with the vagaries of the weather,” said Ser©. “But climate change will stretch their adaptive capacity beyond its limits, as recent severe drought in the region has made abundantly clear. Let’s not leave rural people to fend for themselves but rather invest significantly in helping them build a more viable future.”

On the Net:

Half Of US Children Will Be On Food Stamps

With the present recession in tow, the number of children on food stamps is expected to increase. 

According to researchers, current statistics suggest that approximately half of the children in the U.S., including 90 percent of children who grow up in single-parent households and 90 percent of black children, will be on food stamps at some point between the ages of 1 and 20.

Performed by researchers at Cornell University, the study is based on an analysis of the Panel Study of Income Dynamics, which followed about 4,800 households in the U.S. over the course of 32 years.

The authors of the study wrote background information for the article saying, “Research has repeatedly demonstrated that two of the most detrimental economic conditions affecting a child’s health are poverty and food insecurity.”

Food stamps are part of a Department of Agriculture program for low-income individuals and families, covering most foods. A family of four is eligible if the annual take-home pay does not exceed around $22,000.

“Understanding the degree to which American children are exposed to the risks of poverty and food insecurity across the length of childhood would appear to be an essential component of pediatric knowledge, particularly in light of the growing emphasis on the importance of community pediatrics,” they wrote.

Poverty is estimated to result in rising costs on children’s health care by approximately $22 billion per year.

“Children in poverty are significantly more likely to experience a range of health problems, including low birth weight, lead poisoning, asthma, mental health disorders, delayed immunization, dental problems and accidental death,” wrote Hirschl and co-author Mark R. Rank of Washington University in St. Louis.

“Poverty during childhood is also associated with a host of health, economic and social problems later in life.”

“Such events have the potential to seriously jeopardize a child’s overall health,” the authors added.

However, the chances of living in families using food stamps is not equally shared across all people groups.

Ninety percent of black children live in households receiving food stamps (as opposed to 37 percent of white children), 90 percent of children who live with single parents receive them (contrasted with 37 percent who live in married and other two-parent households),  and 62 percent of those whose head of household did not graduate from high school (contrasted with 31 percent where the head has more than 12 years of school) “encounter spells of food stamp use,” the authors wrote.

With these risk factors put together, the study found that 97 percent of black children living in non-married families where the head of the household did not complete 12 years of education will have received food stamps, compared with 21 percent of white children living in married families whose head of household has 12 or more years of education.

“The situation is likely bad for children,” wrote Hirschl, “because families eligible for food stamps who participate tend to be worse off nutritionally than eligible families who don’t participate.”

Hirschl went on to say that only about 60 percent of families eligible for food stamps actually utilize the program because of the shame and stigma associated with depending on government assistance.

The study was published Nov. 2 in the Archives of Pediatrics and Adolescent Medicine.

On the Net:

Precise Picture Of Early Universe Supports ‘Dark Matter’ Theory

A detailed picture of the seeds of structures in the universe has been unveiled by an international team co-led by a Cardiff University scientist.

The team has obtained extremely precise data about the early universe, using a telescope near the South Pole in the Antarctic.

Their measurements of the cosmic microwave background – a faintly glowing relic of the hot, dense, young universe – provide further support for the standard cosmological model of the universe. The findings confirm the model’s prediction that dark matter and dark energy make up 95% of everything in existence, while ordinary matter makes up just 5%.

In a paper published in the November 1 issue of The Astrophysical Journal, researchers on the QUaD telescope project have released detailed maps of the cosmic microwave background (CMB). The researchers focused their measurements on variations in the CMB’s temperature and polarization to learn about the distribution of matter in the early universe. Polarization is the direction in which vibrations travel from all light rays, which is at right angles to the ray’s direction of travel.

The light from the early universe was initially unpolarized but became polarized when it struck moving matter in the very early universe. By creating maps of this polarization, the QUaD team was able to investigate not just where the matter existed, but also how it was moving. The results very closely match the temperature and polarization predicted by the existence of dark matter and dark energy in the standard cosmological model.

The team was jointly led by Professor Walter Gear, Head of the School of Physics and astronomy at Cardiff University and Professor Sarah Church of the Kavli Institute for Particle Astrophysics and Cosmology (KIPAC), jointly located at the Department of Energy’s SLAC National Accelerator Laboratory and Stanford University.

Professor Gear said: “Studying the CMB radiation has given us extremely precise pictures of the Universe at just 400,000 years old. When we first started working on this project the polarization of the CMB hadn’t even been detected and we thought we might be able to find something wrong with the theory. The fact that these superb data fit the theory so beautifully is in many ways even more amazing. This reinforces the view that researchers are on the right track and need to learn more about the strange nature of dark energy and dark matter if we are to fully understand the workings of the universe.”

Michael Brown, of the Kavli Institute for Cosmology at the University of Cambridge, lead author of the new study added: “With these new QUaD measurements, we have tested further our standard model of the Universe. Reassuringly, the model has passed this test remarkably well.”

Professor Sarah Church, Deputy Director of KIPAC, said: “When I first started in this field, some people were adamant that they understood the contents of the universe quite well. But that understanding was shattered when evidence for dark energy was discovered. Now that we again feel we have a very good understanding of what makes up the universe, it’s extremely important for us to amass strong evidence using many different measurement techniques that this model is correct, so that this doesn’t happen again.”

The QUaD (QUEST at DASI) project utilizes the Q U Extra-galactic Survey Telescope (QUEST) instrument at the South Pole that was installed on the mechanical structure from a previous experiment called DASI (Degree Angular Scale Interferometer).

The principal members of the QUaD collaboration are Cardiff University (United Kingdom), the Kavli Institute for Particle Astrophysics and Cosmology at Stanford University and the Department of Energy’s SLAC National Accelerator Laboratory, the Kavli Institute for Cosmological Physics at the University of Chicago, the California Institute of Technology, the Jet Propulsion Laboratory, Cambridge University (United Kingdom), University of Edinburgh (United Kingdom) and Maynooth College (Ireland).

The Science and Technology Facilities Council (formerly the Particle Physics and Astronomy Research Council ) funded the U.K portion of the research. The National Science Foundation funded the U.S. portion of the experiment, and Research and Enterprise Ireland funded the Irish contribution.

The Standard Model of the cosmos

Although successful, the standard model of the cosmos is also rather absurd – it proposes that the Universe is dominated by two components, neither of which we can see directly. The first is dark matter, an entirely new kind of matter that appears to suffuse our galaxy (and others) without interacting with the ordinary matter of which stars, planets, and humans are made. The second component is even more mysterious – a strange substance known as “dark energy”- energy of empty space itself. The presence of dark energy means that the Universe is not just expanding, but that the expansion is accelerating. The exact nature of dark energy is unknown, but it is possible that the acceleration will continue until ““ albeit many billions of years in the future ““ it rips the Universe apart.

Image Caption: The QUaD collaboration uses the 2.6m telescope shown here to view the temperature and polarization of the cosmic microwave background, a faintly glowing relic of the hot, dense, young universe. Credit: Cardiff University

On the Net:

Science Begins At World’s Most Powerful X-ray Laser

The first experiments are now underway using the world’s most powerful X-ray laser, the Linac Coherent Light Source, located at the Department of Energy’s SLAC National Accelerator Laboratory. Illuminating objects and processes at unprecedented speed and scale, the LCLS has embarked on groundbreaking research in physics, structural biology, energy science, chemistry and a host of other fields.

In early October, researchers from around the globe began traveling to SLAC to get an initial glimpse into how the X-ray laser interacts with atoms and molecules. The LCLS is unique, shining light that can resolve detail the size of atoms at ten billion times the brightness of any other manmade X-ray source.

“No one has ever had access to this kind of light before,” said LCLS Director Jo Stöhr. “The realization of the LCLS isn’t only a huge achievement for SLAC, but an achievement for the global science community. It will allow us to study the atomic world in ways never before possible.”

The LCLS is a testament to SLAC’s continued leadership in accelerator technology. Over 40 years ago, the laboratory’s two-mile linear accelerator, or linac, was built to study the fundamental building blocks of the universe. Now, decades later, this same machine has been revitalized for frontier research underway at the LCLS.

After SLAC’s linac accelerates very short pulses of electrons to 99.9999999 percent the speed of light, the LCLS takes them through a 100-meter stretch of alternating magnets that force the electrons to slalom back and forth. This motion causes the electrons to emit X-rays, which become synchronized as they interact with the electron pulses over this long slalom course, thereby creating the world’s brightest X-ray laser pulse. Each of these laser pulses packs as many as 10 trillion X-ray photons into a bunch that’s a mere 100 femtoseconds long””the time it takes light to travel the width of a human hair.

Currently, user-assisted commissioning is underway, with researchers conducting experiments using the Atomic, Molecular and Optical science instrument, the first of six planned instruments for the LCLS. In these first AMO experiments, researchers are using X-rays from the LCLS to gain an in-depth understanding of how the ultra-bright beam interacts with matter.

Early experiments are already revealing new insights into the fundamentals of atomic physics and have successfully proven the machine’s unique capabilities to control and manipulate the underlying properties of atoms and molecules. Earlier this month, researchers used the LCLS’s strobe-like pulses to completely strip neon atoms of all their electrons. Researchers also watched for two-photon ionization””an event where two photons pool their energy to eject a single electron from an atom. Normally difficult to observe at X-ray facilities, researchers at the LCLS were able to study these events using the extreme brightness of the laser beam.

Future AMO experiments will create stop-action movies of molecules in motion. The LCLS’s quick, short, repetitive X-ray bursts enable researchers to take individual photos as molecules move and interact. By stringing together many such images to make a movie, researchers will for the first time have the ability to watch the molecules of life in action, view chemical bonds forming and breaking in real time, and see how materials work on the quantum level.

By 2013, all six LCLS scientific instruments will be online and operational, giving researchers unprecedented tools for a broad range of research in material science, medicine, chemistry, energy science, physics, biology and environmental science.

“It’s hard to overstate how successful these first experiments have been,” said AMO Instrument Scientist John Bozek. “We look forward to even better things to come.”

Image Caption: Thirty-three LCLS undulator magnets create intense X-ray laser light from a pulse of electrons traveling 99.9999999 percent the speed of light. Credit: Image courtesy of Brad Plummer, SLAC.

On the Net:

Short-Term Hormone Therapy Plus Radiation Ups Survival For Medium-Risk Prostate Cancer Patients

Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

This phase III study is one of the largest clinical trials of prostate cancer therapy ever completed, with 2,000 low- and intermediate-risk patients enrolled in the trial from October 1994 to April 2001. Researchers from the Radiation Therapy Oncology Group (RTOG) followed men with early-stage prostate cancer for a period in most cases of more than nine years. This timeframe was sufficient to show improved survival benefits of short-term hormone therapy added to what was then the standard radiation treatment for prostate cancer, which involved slightly lower doses of radiation than are currently used today with newer techniques, such as intensity modulated radiation therapy (IMRT).

“The study provides strong scientific evidence that shows us when to deliver hormone therapy with radiation in patients with localized prostate cancer,” Christopher U. Jones, M.D., an author of the study and a radiation oncologist at Radiological Associates of Sacramento in Sacramento, Calif., said. “Our findings show that men with low-risk disease, which is the vast majority of prostate cancer patients, have little to gain from adding hormone therapy to radiation. However, men with intermediate-risk disease, which is a significant minority of patients, gain a benefit in overall survival from the addition of only four months of hormone therapy. Prior to this trial, it was unclear whether or not combining hormone therapy with radiation for medium-risk prostate cancer patients improves survival.”

Androgen deprivation therapy is hormone therapy used to treat prostate cancer by stopping or lowering the level of male hormones, or androgens, thereby removing the strongest growth factor for prostate cancer cells.

In the study, a total of 1,979 eligible men who had cancer confined to the prostate and a PSA less than or equal to 20 were randomized to receive total androgen deprivation therapy two months prior to and two months during radiation treatment, or radiation alone.

Findings show that short-term hormone therapy given to early-stage prostate cancer patients prior to and during radiation treatment significantly increases their chance of living longer (51 percent), compared to those who receive radiation alone (46 percent). Nearly all of the survival benefit was in the intermediate-risk group. Secondary endpoints of disease-free survival, freedom from biochemical failure, and positive two year re-biopsy rates were also better in the group who received short-term hormone therapy and radiation treatment.

The study was supported by grants from the National Cancer Institute.

The abstract, “Short-Term Endocrine Therapy Prior To and During Radiation Therapy Improves Overall Survival in Patients with T1b-T2b Adenocarcinoma of the Prostate and PSA ⓰¤20: Initial Results of RTOG 94-08,” will be presented at the plenary session at 2:15 p.m. on Monday, November 2, 2009.

On the Net:

Space Challenge Gives NASA Run for Its Money

Just days after NASA ran a test launch of its spiffy new Ares I-X rocket at the Kennedy Space Center in Florida, a small but devout band of creative space geeks have been trying their hand at rocket science in the middle of the Mojave Desert.

On shoestring budgets that probably wouldn’t suffice to pay the salary of NASA’s personnel for a day, four privately sponsored teams have been competing in the Northrop Grumman Lunar Lander Challenge for a chance to win $2 million in total prize money in six different tasks. 

The NASA-sponsored contest is part of a long-term project which aims to stimulate private individuals and companies into developing potentially cost-effective means of carrying out basic space tasks.  NASA hopes that private entrepreneurs might one day be able to save taxpayers millions of dollars by providing routine space services for a fraction of the money that the federal space agency currently dishes out.

The Ares I-X, which NASA tested on Tuesday, cost U.S. taxpayers upwards of half a billion dollars to get from the drawing board into the atmosphere.  By contrast, the average cost of the privately funded lunar modules taking part in this week’s contest was around $2 million.

One of the companies participating in the space challenge, Masten Space Systems, shot their 10-foot-tall rocket, Xoie, successfully into the air on Friday after a nearly disastrous fire on Thursday that threatened to put the company’s rocket out of commission.

Though official results won’t be announced until later in the week, insiders say that Masten’s craft took a clear lead in the competition on Friday, largely on account of its impressively accurate landing.

The official Lunar Lander Challenge rules require the competitors to navigate their remote-controlled lunar modules between two moon-mimicking launch pads located 50 meters (164 feet) apart.  The rockets must travel from launch pad A to launch pad B and back, and must remain in flight for a minimum of 180 seconds for each leg of the trip.  In addition, the vessels have to rise to a minimum altitude of 50 meters above the ground, and the whole venture must be completed in less than 135 minutes.

Dave Masten, owner of Masten Space Systems, says his long-term aspirations for his company include more than just becoming NASA’s lunar pageboy.  He says he would ultimately like to travel into orbit aboard his own ship “” an ambition shared in part by other competitors in the program who say they see a much more lucrative future in someday using their technology to provide private space tourism flights.

With just a few days left in the competition, the Texas-based team, Armadillo Aerospace, is trailing close on Masten’s heels. The father-son team Unreasonable Rocket has still got a chance to overtake Masten in their launch on Sunday afternoon.

After being plagued by a scourge of technical problems all week, Paul Breed of the Unreasonable Rocket duo admitted that their chances of besting Masten were a long shot.

“It’s still a Hail Mary to be ready for the 180, but we are not yet dead,” said Breed on his team’s blog this weekend.

All in all, the competition has been a roller-coaster ride for both participants and observers.

“The drama has just been unbelievable,” Stuart Witt, GM of the Mojave Air and Space Port told MSNBC reporters.

“I’m really proud of all the teams,” he added, “regardless of the winners.”

On the Net:

Skinny Is Dangerous For Dialysis Patients

Very low body fat linked to increased risk of death

Dialysis patients with low body fat are at increased risk of death””even compared to patients at the highest level of body fat percentage, according to research presented at the American Society of Nephrology’s 42nd Annual Meeting and Scientific Exposition in San Diego.

“Our study indicates that body fat may be protective in dialysis patients,” comments Kamyar Kalantar-Zadeh, PhD (LABioMed at Harbor-UCLA). “The results add to the increasing number of reports about the ‘obesity paradox’ or ‘reverse epidemiology’ in patients with chronic kidney disease and other chronic diseases.” The research will be presented by Youngmee Kim, RN.

Nephrologists have puzzled over the “obesity paradox” in dialysis patients, Kalantar-Zadeh explains. “Counter-intuitively, higher body mass index is associated with greater survival in hemodialysis patients. We hypothesized that very low body fat””less than ten percent””would be a strong predictor of mortality.”

Using near-infrared interactance technology, the researchers measured body fat percentage in 671 hemodialysis patients from eight California dialysis centers. They then compared five-year mortality rates for patients at different levels of body fat percentage.

The mortality rate was highest for dialysis patients with less than 10 percent body fat””2.5 to 3 times higher than for those with body fat of 20 to 30 percent. The increased risk of death for patients with very low body fat remained after adjustment for age, sex, race, other illnesses, and key laboratory results.

Further analyses using continuous values of body fat (rather than categories) confirmed a direct, linear relationship between body fat and mortality risk: “The higher the body fat, the greater the survival,” said Kalantar-Zadeh. Although more research is needed, the results suggest that the obesity paradox may be explained by an increased risk of death for patients with very low body fat, compared to those with average””or even very high””body fat percentage.

The observational study had the same limitations as other epidemiological studies, Kalantar-Zadeh points out. “In addition, we estimated body fat by measuring the subcutaneous fat of the upper arm, which may be different from the intra-abdominal fat.”

The study was sponsored by grants from the National Institutes of Health (NIH). Study co-authors include Youngmee Kim, RN, FNP, PhD; Claudia Luna; Amanda Luna; Allen R Nissenson, MD; Debbie Benner, MS, RD; and Csaba P Kovesdy, MD.

The study abstract, “Association of Body Fat and Survival in Hemodialysis Patients,” (SA-PO2567) was presented as part of a Poster Session during the American Society of Nephrology’s 42nd Annual Meeting and Scientific Exposition on Oct. 31.

On the Net:

Some Mushrooms Harbor More Metals Than Others

A research team from the University of Castilla-La Mancha (UCLM) has analyzed the presence of heavy metals in 12 species of mushroom collected from non-contaminated natural areas, and has found that the levels vary depending on the type of mushroom. The results of the study, which appears this month in the journal Biometals, show that the largest quantities of lead and neodymium are found in chanterelles.

“The aim was to find out if there is a connection between the concentrations of specific heavy metals detected in the mushrooms, based on three factors: the type of substrate, the study area and the species of mushroom. The third was the determining factor”, explains Juan Antonio Campos, principal author of the study and researcher at the Department of Crop Production and Agricultural Technology at UCLM.

The researchers have analyzed the presence of lead (Pb), neodymium (Nd), thorium (Th) and uranium (U) in a hundred samples of 12 different species of common mushroom, both edible and non-edible, collected from non-contaminated zones in the Ciudad Real province. They were collected from wooded areas comprising Holm oak, Kermes oak, Pyrenean oak, Pine and Cistus.

The results of the study, published this month in the journal Biometals, reveal that there are ‘considerable’ quantities of the four metals in all the species examined, as well as significant differences in the capacity for accumulation of these elements depending on the species.

The analysis of these heavy metals ““ which can be toxic to humans ““ was carried out using X-ray fluorescence spectometry, a technique that enables a sample’s composition to be detected and quantified using X-rays.

The highest levels of neodymium (7.1 micrograms/gram) and lead (4.86 µg/g) were found in the chanterelle (Cantharellus cibarius), a mushroom widely used in European cuisine. This mushroom grows in the shadow of Holm oaks, Cork oaks and oaks, and is ectomycorrhizal (it clings to the external roots of plants to exchange nutrients), thereby it has direct contact with the mineral particles of the soil.

For their part, thorium and uranium accumulated mostly in Hypholoma fasciculare, with concentrations of 3.63 and 4.13 µg/g, respectively, “despite being a species that lives on fallen tree trunks and is isolated from the mineral substances of the soil”.

The scientists found no significant differences in the metal levels when comparing mushrooms collected from different substrates, habitats and localizations. The only exception was with thorium, which accumulates more in mushrooms which grow on wood (such as Hypholoma fasciculare or Gymnopilus spectabilis) than in those which have contact with the organic material of the soil (Tricoloma ustaloides and Pisolithus arrhizus).

New lines of research

To confirm that the type of substrate can take on a more important role than reflected in the study, the researchers have embarked on a new project in which they will analyze the presence of 19 chemical elements (toxic and non-toxic) in 15 species of edible mushroom.

“The real issue is that those mushrooms that form ectomycorrhizae are specially adapted to absorb chemical elements from the mineral particles of the soil, and give them to the plant. This is their contribution to symbiosis, and, the more effective they are in providing nutritional elements to the plant, the closer their connection to it, and the more sugars from photosynthesis they can access, which is what they are ultimately looking for”, explains Juan Antonio Campos.

This type of mushroom carries out an indiscriminate acid attack on the mineral particles of the soil and absorbs elements in quantities relative to the mineralogical composition of the soil. “In some contaminated soils, or those with particular mineralogical characteristics, the mushrooms collected can reach such high concentrations of toxic elements that their consumption would be unadvisable”, reveals the researcher.

* Juan A. Campos, Noel A. Tejera y Carlos J. Sánchez. “Substrate role in the accumulation of heavy metals in sporocarps of wild fungi”. Biometals 22 (5): 835-841, octubre de 2009.

Image Caption: Heavy metals accumulate more in some mushrooms than in others. Credit: SINC

On the Net:

Heat Shock Protein Inhibitor Is Potential Anticancer Drug

Like yoga for office drones, cells do have coping strategies for stress. Heat, lack of nutrients, oxygen radicals ““ all can wreak havoc on the delicate internal components of a cell, potentially damaging it beyond repair. Proteins called HSPs (heat shock proteins) allow cells to survive stress-induced damage. Scientists have long studied how HSPs work in order to harness their therapeutic potential.

Donna George, PhD, Associate Professor of Genetics, and Julie Leu, PhD, Assistant Professor of Genetics, both at the University of Pennsylvania School of Medicine, in collaboration with the lab of Maureen Murphy, PhD at Fox Chase Cancer Center, identified a small molecule that inhibits the heat shock protein HSP70. They also showed that the HSP inhibitor could stop tumor formation and significantly extend survival of mice. They describe their findings in this month’s issue of Molecular Cell.

HSP70 is an intracellular quality control officer, refolding misfolded proteins and preventing protein aggregation, which among other disorders, is associated with neurodegenerative diseases. HSP70 also ferries proteins to their proper intracellular locations. Tumor cells, which face an abundance of cellular stresses, typically overexpress HSP70, making it a potentially interesting anticancer target.

The cancer microenvironment exposes malignant cells to a variety of stressful conditions that promote protein misfolding. HSP70 helps cancer cells deal with this stress. Unlike normal cells, which typically express little, if any, of HSP70, cancer cells contain high levels of this protein all of the time. Indeed, HSP70 has been termed a cancer-critical survival factor, since cancer cells probably require the actions of this protein to survive the protein-altering adverse conditions. The inhibitor, called PES, interferes with the HSP70 activities that the cancer cell needs to survive, so by targeting HSP70, one can target the cancer cell.

The investigators showed that PES interacts with HSP70 by blocking its stress-relieving functions. It also induces HSP70-dependent cell death by disrupting the cell’s ability to remove damaged components. Paradoxically for a compound first identified for blocking the cell-death pathway of apoptosis, PES does kill cells, but by a different mechanism.

PES seems to be specifically targeting HSP70, a protein that is differentially expressed in normal versus cancerous cells, and “one that the cancer cell seems to require to survive” says George. “It’s still early days ““ we don’t know what it will do in a human. But, the exciting part is that this is a pathway and a protein target that clearly is important for cancer cells.”

Given the extreme heterogeneity of cancer cells, simultaneously disabling networks of signaling pathways may be important. Indeed, PES was more or less equally effective in every type of cancer cell tested, she says, “which is unusual and supports the idea that it is targeting a protein that is required for the functioning of multiple pathways.”

To figure out just what PES was doing Leu chemically tagged it to see what proteins it interacted with. They were surprised and excited to have pulled out HSP70.

Next, the team investigated the consequences of PES binding. Like many proteins, HSP70 doesn’t act alone; it functions through a cadre of interacting proteins, which augment its activity. So, the team systematically scanned these proteins, to see if PES blocked their interactions with HSP70. “We found several known HSP70-interacting proteins that were no longer interacting properly when the cells were exposed to the small molecule,” Leu notes.

Among those were proteins that help HSP70 refold misfolded proteins and proteins that abet its protein trafficking functions.

When they then studied the effect that loss of those functions had on the cell, the team discovered that PES blocks the cell’s ability to get rid of the proteins damaged by cellular stress in a process called autophagy, a process in which cells were basically eating themselves to death. In mice, Murphy and her students Julia Pimkina and Amanda Frank found that PES could inhibit tumor formation and significantly extend survival.

“That was one of the highlights from our perspective, because PES has potential to be developed as a therapeutic,” says Murphy.

PES should also be a boon to researchers trying to untangle the biology of HSP70, say the researchers. Other HSP70 inhibitors exist but they are neither generally available, nor sufficiently specific. It also provides a novel platform for anticancer therapeutics, either directly as a treatment, or as a starting point for further development.

The research was funded by the National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases.

Image Caption: This image shows an accumulation of holes, called vacuoles, inside a cell, which are associated with protein aggregation and disrupted regulation of normal protein degradation processes following exposure of cells to the HSP70 inhibitor. Credit: Donna George, PhD, University of Pennsylvania School of Medicine

On the Net:

Cigarettes, Alcohol More Dangerous Than Illegal Drugs

The UK government’s top drug advisors said on Thursday that alcohol and cigarettes pose a greater risk to one’s health than hard drugs like cannabis, LSD and ecstasy.

Professor David Nutt of Imperial College London is requesting a new system for classifying drugs so that the public can have a greater understanding of the relative harm of legal and illegal substances, reported AFP.

In a briefing paper for the Center for Crime and Justice Studies at King’s College at London, he reported that alcohol ranks as the fifth most harmful drug after heroin, cocaine, barbiturates and methadone.

Tobacco came in ninth on the list and cannabis, LSD and ecstasy “while harmful, are ranked lower at 11, 14 and 18 respectively”.

The ranking is based on physical harm, dependence and social harm.

“No one is suggesting that drugs are not harmful. The critical question is one of scale and degree,” said Nutt, the chairman of the government’s Advisory Council on the Misuse of Drugs.

“We have to accept young people like to experiment, with drugs and other potentially harmful activities, and what we should be doing in all of this is to protect them from harm at this stage of their lives,” he added.

“We therefore have to provide more accurate and credible information. If you think that scaring kids will stop them using, you are probably wrong.”

Nutt disagreed with the ministers’ decision to bump the classification of cannabis in January from class C, which includes tranquillizers and some painkillers, to the higher class B alongside amphetamines.

This went against scientific advice and came only five years after cannabis was dropped from class B to C. Under this decision, penalties would be increased to a maximum 14 years in jail for dealing and five years for possession.

According to Nutt, such policies “distort” and “devalue” research evidence and give contradicting messages to the public.

He admitted that cannabis was “harmful”, and that its use does not lead to major health issues. Cannabis users had a “relatively small risk” of psychotic illness when compared to the risks of smokers contracting lung cancer.

Nutt had already stirred up talk earlier this year when he claimed that taking ecstasy was no more dangerous than horseriding, which he reiterated in his paper.

On the Net:

Th17 Cells Summon Immune System Strike Against Cancer

Helper T cell’s effect raises possibility of cellular therapy, vaccine development

A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson Cancer Center report in the early online edition of the journal Immunity.

The role of Th17, one of only four known types of T helper cell, opens a possible avenue for overcoming cancer’s ability to suppress or hide from the body’s immune system, said senior author Chen Dong, Ph.D., professor in M. D. Anderson’s Department of Immunology. Dong and colleagues found that Th17 stifled development of metastatic melanoma tumors in the lungs of mice.

“While there is much work to be done, these preclinical findings imply the possibility of taking a patient’s Th17 cells, expanding them in the lab, and then re-infusing them as treatment,” Dong said. Development of a vaccine to stimulate Th17 cells would be another possible application.

Dong earlier discovered the existence of Th17 cells and established that they secrete the inflammatory protein interleukin-17 (IL-17). His lab showed that overexpression of IL-17 contributes to both autoimmune and inflammatory diseases.

“Th17 cells also are found in a variety of solid tumors and we wanted to know whether these cells promote cancer or play a preventive or protective role,” Dong said.

Their research showed that mice made deficient in Th17 cells and then injected with a strain of melanoma that gathers in the lungs experienced aggressive cancer growth compared to mice with normal levels of Th17. At 16 days, tumors in the knockout mice had fused together and coated the lung so extensively that they were no longer countable.

Next, they tested Th17 for preventive effect, injecting Th17 cells primed with tumor-specific antigens and the melanoma cells at the same time. At 16 days, mice with Th17 had low or barely detectable levels of cancer while control mice had a heavy tumor burden in their lungs.

A third set of experiments tested a treatment effect, showing that mice injected with Th17 after they already had melanoma in their lungs had a 75 percent reduction in tumor burden compared with normal mice.

In all experiments, mice with Th17 also had higher levels of several categories of immune system cell than did those with normal or suppressed Th17.

T cells are lymphocytes, a type of white blood cell produced by the thymus equipped with receptors that recognize and bind to antigens, pieces of invading organisms presented to the T cells by dendritic cells. The bound antigen converts the T cell to T helper cells that secrete signaling molecules called cytokines to launch an appropriate immune response. Helper cells, in effect, guide the adaptive immune response.

In the Immunity paper, additional experiments outlined the specific pathway by which Th17 suppresses tumors:

* Tumor invasion of the lung attracts Th17 cells that secrete IL-17A.

* IL-17A in turn promotes the secretion of two chemokines, CCL2 and CCL20, which recruit leukocytes to the tumor site.

* The leukocytes include dendritic cells, which seize tumor antigens and migrate to the lymph nodes.

* There, the antigens are used to prime CD8+ killer cells, which then migrate to the lung and kill established tumors.

The research was funded by grants from the National Institutes of Health, M. D. Anderson’s Center for Targeted Therapy, a Leukemia and Lymphoma Society Scholar Award to Dong, and a Trust Fellowship of M. D. Anderson.

Co-authors with Dong and first author Natalia Martin-Orozco, Ph.D., are Yeonseok Chung, Ph.D., Xuexian O. Yang, Ph.D., and Tomohide Yamazaki, all of the Department of Immunology; Pawel Muranski, M.D., and Nicholas Restifo, M.D., both of the National Cancer Institute of the National Institutes of Health; Sijie Lu, Ph.D., of M. D. Anderson’s Department of Stem Cell Transplantation and Cell Therapy; and Patrick Hwu, M.D., and William Overwijk, Ph.D., both of M. D. Anderson’s Department of Melanoma Medical Oncology.

On the Net:

AIDA Aims To Change How We Interact With Our Car

MIT researchers and designers are developing the Affective Intelligent Driving Agent (AIDA) – a new in-car personal robot that aims to change the way we interact with our car. The project is a collaboration between the Personal Robots Group at the MIT Media Lab, MIT’s SENSEable City Lab and the Volkswagen Group of America’s Electronics Research Lab.

“With the ubiquity of sensors and mobile computers, information about our surroundings is ever abundant. AIDA embodies a new effort to make sense of these great amounts of data, harnessing our personal electronic devices as tools for behavioral support,” comments professor Carlo Ratti, director of the SENSEable City Lab. “In developing AIDA we asked ourselves how we could design a system that would offer the same kind of guidance as an informed and friendly companion.”

AIDA communicates with the driver through a small robot embedded in the dashboard. “AIDA builds on our long experience in building sociable robots,” explains professor Cynthia Breazeal, director of the Personal Robots Group at the MIT Media Lab. “We are developing AIDA to read the driver’s mood from facial expression and other cues and respond in a socially appropriate and informative way.”

AIDA communicates in a very immediate way: with the seamlessness of a smile or the blink of an eye. Over time, the project envisions that a kind of symbiotic relationship develops between the driver and AIDA, whereby both parties learn from each other and establish an affective bond.

To identify the set of goals the driver would like to achieve, AIDA analyses the driver’s mobility patterns, keeping track of common routes and destinations. AIDA draws on an understanding of the city beyond what can be seen through the windshield, incorporating real-time event information and knowledge of environmental conditions, as well as commercial activity, tourist attractions, and residential areas.

“When it merges knowledge about the city with an understanding of the driver’s priorities and needs, AIDA can make important inferences,” explains Assaf Biderman, associate director of the SENSEable City Lab. “Within a week AIDA will have figured out your home and work location. Soon afterwards the system will be able to direct you to your preferred grocery store, suggesting a route that avoids a street fair-induced traffic jam. On the way AIDA might recommend a stop to fill up your tank, upon noticing that you are getting low on gas,” says Biderman. “AIDA can also give you feedback on your driving, helping you achieve more energy efficiency and safer behavior.”

AIDA was developed in partnership with Audi, a premium brand of the Volkswagen Group, and the Volkswagen Group of America’s Electronics Research Lab. The AIDA team is directed by Professor Cynthia Breazeal, Carlo Ratti, and Assaf Biderman. The SENSEable City Lab team includes team leader Giusy di Lorenzo and includes Francisco Pereira, Fabio Pinelli, Pedro Correia, E Roon Kang, Jennifer Dunnam, and Shaocong Zhou. The Personal Robots Group’s technical and aesthetic team includes Mikey Siegel, Fardad Faridi and Ryan Wistort as well as videographers Paula Aguilera and Jonathan Williams. Chuhee Lee and Charles Lee represent the Volkswagen Group of America’s Electronics Research Lab.

Images Courtesy MIT SENSEable City Lab and Personal Robots Group of Media Lab

On the Net:

Dietary Fiber Helps Immune Response

Australian researchers say they may have found yet another reason why we ought to be packing our diets full of fresh fruits and vegetables.  According to a new study released by Sydney’s Garvan Institute of Medical Research, dietary fiber isn’t just important for keeping your grandmother regular, but may in fact play a significant role in staving off chronic illnesses like arthritis, diabetes and asthma.

Researchers have for some time known that fiber-rich foods such as legumes, whole grain breads and fresh fruits and vegetables are processed by intestinal bacteria to produce byproducts known as short chain fatty acids “” biomolecules that naturally treat various inflammatory diseases of the bowels.

According to Professor Charles Mackay of the Garvan Institute, his group “” which collaborated with research labs in the U.S. and Brazil “” was able to more closely elucidate the nature of the effects of fiber on intestinal disorders, which they believe may have much broader implications for our understanding of the relationship between diet and immune response.

In short, Professor Mackay and PhD student Kendle Maslowski were able to show that a molecule known as GPR43 “” known to be present in immune cells and used to bind short chain fatty acids “” also doubles as an anti-inflammatory receptor.

“The important point about our work is that we provide the molecular explanation that links fiber in the diet to the micro-organisms in our gut to the affect on the immune response,” Professor Mackay told AFP.

The team’s work, published in the current edition of Nature, points to a potential link between diet and immune responses that has hitherto been the subject of guesswork.

“The notion that diet might have profound effects on immune responses or inflammatory diseases has never been taken that seriously,” explained Professor Mackay.

“We believe that changes in diet, associated with western lifestyles, contribute to the increasing incidences of asthma, Type 1 diabetes and other autoimmune diseases. Now we have a new molecular mechanism that might explain how diet is affecting our immune systems.”

According to Maslowski, taking care of the friendly bacteria that make their homes in our gut may be much more important to lifelong health than people realize.

“We’re […] beginning to understand that from the moment you’re born, it’s incredibly important to be colonized by the right kinds of gut bacteria,” she explained.

“The kinds of foods you eat directly determine the levels of certain bacteria in your gut [and] changing diets are changing the kinds of gut bacteria we have, as well as their by-products, particularly short chain fatty acids.”

“If we have low amounts of dietary fiber, then we’re going to have low levels of short chain fatty acids, which we have demonstrated are very important in the immune systems of mice.”

In lab studies, the team demonstrated that mice lacking the gene for GPR43 experienced a significantly increased incidence of intestinal inflammation and a diminished ability to fight off existing inflammation, presumably because their immune cells were unable to bind to short chain fatty acids.

The group’s work is corroborated by a 2006 study published in Nature that compared bacteria colonies in the intestines of obese people with those found in leaner subjects.  The obese people were then put on a diet, and scientists observed that as they began to shed pounds the constitution of their bacteria colonies progressively came to look more and more like that seen in the leaner people.

Mackay expressed enthusiasm over the potential that his team’s researcher could help to shed light on this little-understood branch of immunology.

“The role of nutrition and gut intestinal bacteria in immune responses is an exciting new topic in immunology, and recent findings including our own open up new possibilities to explore causes as well as new treatments for inflammatory diseases such as asthma,” said Professor Mackay.

On the Net:

Maize Research Reduces Poverty In West, Central Africa

An analysis of three and half decades of maize research in African farming communities finds big benefits. A multi-country study, in Agricultural Economics, reports the significant role international maize research plays in reducing poverty. It finds that since the mid-1990s, more than one million people per year have escaped poverty through the adoption of new maize varieties.

Key economic benefits from maize research are primarily the result of the productivity gains farmers experience after adopting modern varieties. While notably scant prior to the 1980s, the percentage of MVs found in a maize area grew from 5 % in the 1970s to 60% in 2005. The study results suggest that without research to maintain or increase maize yields, poverty in the region would be substantially worse.

For example, for every $1 million invested in this type of research at The International Institute of Tropical Agriculture (IITA), at least 35,000 people were lifted out of poverty, reports author Arega Alene of IITA (“The Economic and Poverty Impacts of Maize Research in West and Central Africa”).

Alene examines the relationship between variety performance and adoption patterns to estimate the benefits of maize research in West and Central Africa during the past three and half decades. Results are drawn from multiple surveys of research conducted between 1981 and 2005 by IITA, the International Maize and Wheat Improvement Center (CIMMYT), and the national agricultural research systems (NARS). Social rates of return on public investments in maize research in the region were also considerable.

The countries surveyed account for about 85% of maize production in the region. Questionnaire surveys were conducted with managers, breeders, economists, and representatives of maize research institutes and seed production agencies.

Alene concludes that more must be done to enhance the impact of maize research. Affordability and accessibility for farmers to various complementary inputs, such as improved seed and fertilizer, are critical factors for sustainable poverty reduction.

On the Net:

Cameras Zoom In On Cause Of Obstructive Sleep Apnea

The best time to have your picture taken is usually not while you are sleeping, that is unless you suffer from sleep apnea. Doctors at Baylor College of Medicine are using a small video camera inserted into the airway to help pinpoint the cause of obstructions that happen during sleep apnea.

Obstructive sleep apnea is a condition in which tissues in the back of the throat collapse during sleep, resulting in the cessation of breathing, restless sleep, daytime fatigue, loud snoring, as well as frequently waking up gasping for breath.

Airway obstructions

“In the past, most doctors assumed it was always the soft palate and uvula (soft tissue in the back part of the roof of the mouth) that was collapsing, and they would trim portions of it out,” said Dr. Mas Takashima, assistant professor of otolaryngology. “However, as surgical outcomes have shown, this procedure doesn’t have a 100 percent cure rate.”

Takashima says that’s because there are many things other than the soft palate that can obstruct the airway, such as large tonsils, large tongue base, skeletal abnormalities or the epiglottis (the structure that prevents food from entering the trachea during swallowing). Getting an up-close view of these areas with the camera while the patient is asleep helps doctors determine exactly what areas to target.

Pinpointing problem

Patients are sedated, and a drug-induced sleep is obtained so the patient can breath on his or her own. While asleep, an endoscope, a small flexible device with a camera on the end, is inserted into the back of the nose to view the throat. Doctors are able to watch what happens inside the throat as the person sleeps.

By exactly diagnosing the cause of the obstruction, a more precise and directed surgical therapy can be planned.

“Of course you are not going to get a good result if surgery is addressed on your soft palate if the main cause of your sleep apnea is your tongue,” said Takashima.

There are nonsurgical options, such as the CPAP, which requires wearing a breathing mask that blows a continuous stream of air into the throat to keep the airway open when you sleep.

“As long as sleep apnea is treated, whether or not a person wants to undergo surgery is up to them,” Takashima said. “Having the video helps us to understand what surgical options are available, which in turns improves our patient counseling, and more importantly helps prevent unnecessary surgery.”

On the Net:

Compound In Curry Kills Cancer Cells

Scientists said on Wednesday that a molecule found in a curry ingredient kills esophageal cancer cells in the laboratory, suggesting it might be developed as an anti-cancer treatment, Reuters reported.

Curcumin, a chemical found in the spice turmeric, gives curries a distinctive yellow color, but researchers at the Cork Cancer Research Center in Ireland used it to treat esophageal cancer cells and found it started to kill cancer cells within 24 hours.

According to the study published in the British Journal of Cancer, those cells also began to digest themselves.

Studies in the past suggested curcumin can suppress tumors and that people who eat lots of curry may be less prone to the disease.

However, when ingested, curcumin quickly loses its anti-cancer attributes.

But the study suggested a potential for scientists to develop curcumin as an anti-cancer drug to treat esophageal cancer, according to the lead author of the Irish study, Dr. Sharon McKenna.

Over 500,000 people across the world die each year from cancers of the esophagus and only 12 to 31 percent of sufferers receive five-year survival rate.

The new study showed curcumin caused the cancer cells to die “using an unexpected system of cell messages,” McKenna said.

The researchers said that in most cases the faulty cells die by committing programmed suicide, or apoptosis, which occurs when proteins called caspases are ‘switched on’ in cells.

However, these cells showed no evidence of suicide, and the addition of a molecule that inhibits caspases and stops this “switch being flicked’ made no difference to the number of cells that died, suggesting curcumin attacked the cancer cells using an alternative cell signaling system.

In 2007, U.S. researchers said they had found curcumin might help stimulate immune system cells in the Alzheimer’s disease.

“This is interesting research which opens up the possibility that natural chemicals found in turmeric could be developed into new treatments for esophageal cancer,” said Dr. Lesley Walker, director of cancer information at Cancer Research UK.

Walker said that rates of esophageal cancer have gone up by more than a half since the 70s.

“This is thought to be linked to rising rates of obesity, alcohol intake and reflux disease so finding ways to prevent this disease is important too.”

On the Net:

Were Eastern Canary Islands Wetter 50,000 Years Ago?

Fossil land snail shells found in ancient soils on the subtropical eastern Canary Islands show that the Spanish archipelago off the northwest coast of Africa has become progressively drier over the past 50,000 years.

Isotopic measurements performed on fossil land snail shells resulted in oxygen isotope ratios that suggest the relative humidity on the islands was higher 50,000 years ago, then experienced a long-term decrease to the time of maximum global cooling and glaciation about 15,000 to 20,000 years ago, according to new research by Yurena Yanes, a post-doctoral researcher, and Crayton J. Yapp, a geochemistry professor, both in the Roy M. Huffington Department of Earth Sciences at Southern Methodist University in Dallas, Texas.

With subsequent post-glacial climatic fluctuations, relative humidity seems to have oscillated somewhat, but finally decreased even further to modern values.

Consequently the eastern Canary Islands experienced an overall increase in dryness during the last 50,000 years, eventually yielding the current semiarid conditions. Today the low-altitude eastern islands are characterized by low annual rainfall and a landscape of short grasses and shrubs, Yanes says.

The research advances understanding of the global paleoclimate during an important time in human evolution, when the transition from gathering and hunting to agriculture first occurred in the fertile Middle East and subsequently spread to Asia, North Africa and Europe.

“In the Canary Archipelago, land snails are one of the rare ‘continuous’ records of paleoclimatic conditions over the last 50,000 years,” Yanes says. “The results of this study are of great relevance to biologists and paleontologists investigating the evolution of plants and animals linked to climatic fluctuation in the islands.”

The researchers’ isotopic evidence reflects changing atmospheric and oceanic circulation associated with the waxing, waning and subsequent disappearance over the past 50,000 years of vast ice sheets at mid- to high latitudes on the continents of the Northern Hemisphere.

The research also is consistent with the observed decline in diversity of the highly moisture-sensitive land snails.

Land snail shells are abundant and sensitive to environmental change and as fossils they are well-preserved. Measurement of variations in oxygen isotope ratios of fossil shells can yield information about changes in ancient climatic conditions.

The shells are composed of the elements calcium, oxygen and carbon, which are combined to form a mineral known as aragonite. Oxygen atoms in aragonite are not all exactly alike. A small proportion of those atoms is slightly heavier than the majority, and these heavier and lighter forms of oxygen are called isotopes of oxygen.

Small changes in the ratio of heavy to light isotopes can be measured with a high degree of accuracy and precision. Variations in these ratios are related to climatic variables, including relative humidity, temperature and the oxygen isotope ratios of rainwater and water vapor in the environments in which land snails live.

Yanes presented the research at a scientific session of the 2009 annual meeting of The Geological Society of America in Portland, Ore., Oct. 18-21. The research was funded by Spain’s Ministry of Science and Innovation and the National Science Foundation.

Image Courtesy NASA

On the Net:

Who: Five Risk Factors Account For 1/4 Of Preventable Deaths

Global life expectancy could be raised nearly five years by addressing just five health factors ““ unsafe sex, alcohol consumption, poor child nutrition, high blood pressure and lack of safe water, sanitation and hygiene ““ according to a new report released Tuesday by the U.N. World Health Organization (WHO).

These five factors are responsible for nearly one-quarter of the estimated 60 million global deaths each year, said the WHO’s Global Health Risks report, which highlights various environmental, behavioral and physiological factors affecting health.

The report is based on extensive data from the WHO and other studies, and estimates the health effects of 24 risk factors by region, age, sex and country income for the year 2004, the most recent year in which data is available.

These health factors raised the risk of chronic diseases and deaths within “countries across all income groups — high, middle and low,” read the report.

The U.N. health agency listed the world’s top mortality risks as high blood pressure (responsible for 13 percent of deaths), tobacco use (9 percent), high blood glucose (6 percent), physical inactivity (6 percent), and obesity or being overweight (5 percent).

“The world faces some large, widespread and certain risks to health,” read the report.

Identifying and assessing these risks will help policy makers devise strategies to improve health in the most comprehensive and cost-effective ways, said Colin Mathers, the WHO’s Coordinator for Mortality and Burden of Disease.

“Understanding the relative importance of health risk factors helps governments figure out which health policies they want to pursue, ” he said.

“In many countries there is a complex mix of risk factors. Countries can combine this type of evidence along with information about policies and their costs to decide how to set their health agenda.”

“Health risks are in transition: populations are aging owing to successes against infectious diseases; at the same time, patterns of physical activity and food, alcohol and tobacco consumption are changing,” the WHO said.

“As health improves, gains can multiply,” said the Geneva-based agency in its report.

“Reducing the burden of disease in the poor may raise income levels, which in turn will further help to reduce health inequalities.”

Many deaths and diseases are caused by more than one risk factor, the report said, and could be prevented by reducing any of the individual factors.

The report found that eight risk factors account for over three-quarters of deaths from coronary heart disease, the world’s leading killer. These factors include high blood glucose, alcohol consumption, tobacco use, high blood pressure, high body mass index, high cholesterol, low fruit and vegetable intake and lack of physical activity. Most of these deaths occur in developing nations, the WHO said. 

The report also found that nearly half of all cancer deaths worldwide are attributable to nine environmental and behavioral risks and seven infectious causes. 

Meanwhile, “more than one-third of global child deaths can be attributed to a few nutritional risk factors such as childhood underweight, inadequate breastfeeding and zinc deficiency,” said Mathers.

While poor nutrition is a significant health risk among poorer countries, obesity and being overweight are even greater risks in wealthier nations, and are responsible for more deaths globally than being underweight.

The WHO said its study showed that health was becoming “globalized”, and warned that developing countries face a double burden of health risks.

For instance, while some risk factors such as smoking and obesity are typically associated with rich countries, more than three-quarters of the total global burden of diseases they cause take place in poor and developing nations.

“The poorest countries still face a high and concentrated burden from poverty, undernutrition, unsafe sex, unsafe water and sanitation,” it said.

“At the same time, dietary risk factors for high blood pressure, cholesterol and obesity, coupled with insufficient physical activity, are responsible for an increasing proportion of the total disease burden.”

If the risks outlined in the report had not existed, average global life expectancy in 2004 would have been nearly a decade longer, the WHO said.

The WHO’s full Global Health Risks report can be viewed at http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf .

URI Research Couple’s Method Targets Cancerous Tumors

Invents method to deliver treatment

Two University of Rhode Island associate professors, biophysicists Yana Reshetnyak and Oleg Andreev, have discovered a technology that can detect cancerous tumors and deliver treatment to them without the harming the healthy cells surrounding them, thereby significantly reducing side effects. The URI couple has attracted more than $6 million in grants in four years. In addition, a number of health care and pharmaceutical companies have expressed interest in their work.

It is possible, says Andreev, that one day their detection method could be used as a universal procedure, similar to mammography or colonoscopies. Their harmless imaging test could locate a problem before the patient ever feels ill.

The key lies in the acidity level of cells. While normal cells maintain a pH of 7.4 with little variation, cancer cells, expend a great deal of energy as they rapidly proliferate, pumping protons outside and creating an extracellular pH level of 5.5 to 6.5. (The lower the number, the higher the acidity.)

While scientists have known about tumor acidity for years, they had not devised a way to target it. Donald Engelman in the molecular biophysics and biochemistry lab at Yale University discovered the peptide that targets acidity, but had not employed it until Reshetnyak joined his lab as a postdoctoral student in 2003. She and Andreev, then a senior scientist at an anticancer drug delivery company, suggested an investigation into the peptide’s potential as cancer targeting agents.

In 2004, Reshetnyak and Andreev joined the Physics Department at URI and established a biological and medical physics laboratory. The couple continued their collaboration with Engleman and their investigation of the properties of the peptide, now called the pHLIP peptide. After making some modifications to it, they demonstrated that pHLIP could find a tumor in a mouse and deliver imaging or therapeutic agents specifically to cancer cells. The Yale/URI targeting system has a patent pending in the U.S. and Europe.

The researchers suggest their discovery method could be used to monitor other disease development and treatment. It also could play an important role in the study of arthritis, inflammation, infection, infraction, and stroke since those conditions also produce high acidity.

DELIVERY METHOD

In addition to targeting cancerous tumors, the couple has discovered a novel delivery agent, a molecular nanosyringe, which can deliver and inject diagnostic or therapeutic agents specifically to cancer cells.

“Since we know the mechanism of delivery and translocation, we believe that we are able to tune the nanosyringe properties and engineer a novel class of therapeutic and diagnostic agents,” says Reshetnyak.

In a project with the Cancer Center at Rhode Island Hospital, the URI researchers have successfully shown that the peptide can deliver nanogold particles into the cancerous tumor. Once in place, the tiny gold particles can absorb more radiation, providing a more lethal dose to the tumor, but not to surrounding health cells.

“Drs. Reshetnyak and Andreev research offers a potential for a new and more effective approach to the treatment of cancer with radiation, making it highly intriguing and important,” said Edward S. Sternick, medical physicist-in-chief, Department of Radiation Oncology, Rhode Island Hospital and professor and vice chair radiation oncology at the Warren Alpert Medical School of Brown University.

“About 1.6 million new cancer patients are diagnosed annually in the U.S.” says Sternick noting that the number is expected to grow significantly, reaching 2 million cases per year in the next 10 years, a direct reflection of our aging population. Approximately 50 percent of these cancer patients will receive radiation therapy during the course of their disease.

The URI researchers are collaborating on a $1.5 million National Institutes of Heath/National Cancer Institute grant Jason S. Lewis, chief of radiochemistry service at Memorial Sloan-Kettering Cancer Center in Manhattan, New York. “Their research is innovative and exciting,” said Lewis. “It is also timely; the understanding of the tumor microenvironment, and in particular, the pH of a tumor is believed to be important in the metastatic spread of cancer. The technology that the couple has developed could, non-invasively, predict the metastatic potential of cancer as well as or monitoring the effectiveness of potential therapies. Their technology may allow for patient personalized therapies in the future.”

Through URI’s Department of Physics, Reshetnyak and Andreev are collaborating with Rhode Island Hospital on a proposed 5-year degree program that combines medicine and physics. Students would spend four years in college classes and one year at the hospital.

“The proposed URI/RIH medical physics program now under consideration by URI is the first in New England specifically designed to closely integrate academic and clinical preparation,” said Rhode Island Hospital’s Sternick, noting that a residency requirement is required before someone is eligible to take the American Board of Radiology national certification examinations. “Because our post-graduate two-year medical physics residency training program will run parallel with the URI medical physics program, URI students will have the opportunity throughout their University experience to gain valuable experiential insights about career opportunities available to and the responsibilities of physicists working in the field of cancer diagnosis and treatment where nationwide demand for well-trained clinical medical physicists far exceeds the available supply.” One of Andreev’s graduate students, James Segala was accepted into RIH’s competitive residency program.

Once certified, graduates of the program could easily find work and high salaries at hospitals where they would calculate radiation prescriptions for radiologists. They could also opt to earn a doctorate to conduct research and teach at the university level. Or they could also go to private industry where their expertise is needed in the development of medical devices.

On the Net:

Families Suffer From Problem Gambling

Many people perceive gambling to be a harmless recreational activity. However, it is estimated that six to eight million people in the United States personally suffer from a gambling related problem. This problem seems to grow tentacles, extending out to wreak havoc and can profoundly impact the physical, emotional, and financial health of the family (spouses, children, extended).

As stated in this month’s issue of the Journal of Marital and Family Therapy, the most common treatment models for problem gambling are focused on meeting the needs of gamblers but do not address the needs of couples and families whose lives have been negatively impacted by someone else’s gambling. In the paper, the authors provide a detailed description of how problem gambling impacts families, they explain, “Our hope in writing this paper is to raise awareness about problem gambling and the importance of developing treatment programs that meet the needs of the families of problem gamblers.”

As noted by the authors, many of the people who access problem gambling treatment services are family members. It is clear that the impact of gambling on families can no longer be allowed to slip “under the radar”. Marriage and family therapists are well positioned to help families cope with the impact of problem gambling on their lives.

On the Net:

Study Shows That Raising Kids Makes Married People Happier

Having children improves married peoples’ life satisfaction and the more they have, the happier they are.  For unmarried individuals, raising children has little or no positive effect on their happiness. These findings by Dr. Luis Angeles from the University of Glasgow in the UK have just been published online in Springer’s Journal of Happiness Studies.

Previous research suggests that increasing numbers of children do not make people any happier, and in some cases the more children people have, the less satisfied they are with their lives. Rather bleakly, this has been attributed to the fact that raising children involves a lot of hard work for only a few occasional rewards.

Dr. Angeles believes that this explanation is too simplistic. When asked about the most important things in their lives, most people place their children near or even at the top of their list. Contrary to previous work, Dr. Angeles’ analysis of the relationship between having children and life satisfaction takes into account the role of individual characteristics, including marital status, gender, age, income and education.

For married individuals of all ages and married women in particular, children increase life satisfaction and life satisfaction goes up with the number of children in the household. Negative experiences in raising children are reported by people who are separated, living as a couple, or single, having never been married. Children take their toll on their parents’ satisfaction with social life, and amount and use of leisure time.

Dr. Angeles concludes: “One is tempted to advance that children make people better off under the “Ëœright conditions’ – a time in life when people feel that they are ready, or at least willing, to enter parenthood. This time can come at very different moments for different individuals, but a likely signal of its approach may well be the act of marriage.”

* Angeles L (2009). Children and life satisfaction. Journal of Happiness Studies; DOI 10.1007/s10902-009-9168-z

On the Net:

Gene ‘Cancer-Proofs’ Rodent’s Cells

Naked Mole Rat, the Only Known Cancerless Animal, Has Two-Tier Defense Against Cancer

Despite a 30-year lifespan that gives ample time for cells to grow cancerous, a small rodent species called a naked mole rat has never been found with tumors of any kind””and now biologists at the University of Rochester think they know why.

The findings, presented in today’s issue of The Proceedings of the National Academy of Sciences, show that the mole rat’s cells express a gene called p16 that makes the cells “claustrophobic,” stopping the cells’ proliferation when too many of them crowd together, cutting off runaway growth before it can start. The effect of p16 is so pronounced that when researchers mutated the cells to induce a tumor, the cells’ growth barely changed, whereas regular mouse cells became fully cancerous.

“We think we’ve found the reason these mole rats don’t get cancer, and it’s a bit of a surprise,” says Vera Gorbunova, associate professor of biology at the University of Rochester and lead investigator on the discovery. “It’s very early to speculate about the implications, but if the effect of p16 can be simulated in humans we might have a way to halt cancer before it starts.”

Naked mole rats are strange, ugly, nearly hairless mouse-like creatures that live in underground communities. Unlike any other mammal, these communities consist of queens and workers more reminiscent of bees than rodents. Naked mole rats can live up to 30 years, which is exceptionally long for a small rodent. Despite large numbers of naked mole-rats under observation, there has never been a single recorded case of a mole rat contracting cancer, says Gorbunova. Adding to their mystery is the fact that mole rats appear to age very little until the very end of their lives.

Over the last three years, Gorbunova and Andrei Seluanov, research professor of biology at the University of Rochester, have worked an unusual angle on the quest to understand cancer: Investigating rodents from across the globe to get an idea of the similarities and differences of how varied but closely related species deal with cancer.

In 2006, Gorbunova discovered that telomerase””an enzyme that can lengthen the lives of cells, but can also increase the rate of cancer””is highly active in small rodents, but not in large ones.

Until Gorbunova and Seluanov’s research, the prevailing wisdom had assumed that an animal that lived as long as we humans do needed to suppress telomerase activity to guard against cancer. Telomerase helps cells reproduce, and cancer is essentially runaway cellular reproduction, so an animal living for 70 years has a lot of chances for its cells to mutate into cancer, says Gorbunova. A mouse’s life expectancy is shortened by other factors in nature, such as predation, so it was thought the mouse could afford the slim cancer risk to benefit from telomerase’s ability to speed healing.

While the findings were a surprise, they revealed another question: What about small animals like the common grey squirrel that live for 24 years or more? With telomerase fully active over such a long period, why isn’t cancer rampant in these creatures?

Gorbunova sought to answer that question, and in 2008 confirmed that small-bodied rodents with long lifespans had evolved a previously unknown anti-cancer mechanism that appears to be different from any anticancer mechanisms employed by humans or other large mammals.

At the time she was not able to identify just what the mechanism might be, saying: “We haven’t come across this anticancer mechanism before because it doesn’t exist in the two species most often used for cancer research: mice and humans. Mice are short-lived and humans are large-bodied. But this mechanism appears to exist only in small, long-lived animals.”

Now, Gorbunova believes she has found the primary reason these small animals are staying cancer-free, and it appears to be a kind of overcrowding early-warning gene that the naked mole rat expresses in its cells.

When Gorbunova and her team began specifically investigating mole rat cells, they were surprised at how difficult it was to grow the cells in the lab for study. The cells simply refused to replicate once a certain number of them occupied a space. Other cells, such as human cells, also cease replication when their populations become too dense, but the mole rat cells were reaching their limit much earlier than other animals’ cells.

“Since cancer is basically runaway cell replication, we realized that whatever was doing this was probably the same thing that prevented cancer from ever getting started in the mole rats,” says Gorbunova.

Like many animals, including humans, the mole rats have a gene called p27 that prevents cellular overcrowding, but the mole rats use another, earlier defense in gene p16. Cancer cells tend to find ways around p27, but mole rats have a double barrier that a cell must overcome before it can grow uncontrollably.

“We believe the additional layer of protection conferred by this two-tiered contact inhibition contributes to the remarkable tumor resistance of the naked mole rat,” says Gorbunova in the PNAS paper.

Gorbunova and Seluanov are now planning to delve deeper into the mole rat’s genetics to see if their cancer resistance might be applicable to humans.

This research was funded by the National Institutes of Health and the Ellison Medical Foundation.

Image 1: Naked Mole Rats (Credit University of Rochester)

Image 2: ‘The naked mole rats’ p16 gene kicks in early to stop cell overcrowding’

On the Net:

Small Hairy Balls Make Food Healthier

Dutch researcher successfully packages enzymes

Dutch researcher Saskia Lindhoud has discovered a new way to package enzymes by causing charged polymers to form a ‘ball of hair’ around these. Her approach significantly increases the utility of the enzymes. For example, healthy enzymes with a foul taste can be packaged in such a way that they are released in the stomach without being tasted.

Enzymes are molecules that can trigger specific chemical reactions. They are responsible for the taste of beer, the effectiveness of detergents and the digestion of food in our guts. However, the optimal use of enzymes requires that they do not trigger the chemical reactions too early or too late. Moreover, enzymes are quite sensitive to changes in their environment such as temperature fluctuations and changes in the salt concentration or pH. Enzymes can be protected from such influences by means of a packaging. Lindhoud discovered a new way of doing this well.

Hairy balls

Lindhoud used polyelectrolyte complex micelles for the packaging. These consist of at least two types of molecules that have an opposite charge and of which at least one type has a charged and an uncharged block (diblock copolymer). If these molecules are mixed together then the oppositely charged parts of the molecules form a complex because opposite charges attract. The uncharged parts of the molecules prefer not to be located in the core and stick outwards. This results in the automatic formation of balls with hairs on the outside.

As enzymes are also charged they can be packaged into these hairy balls. Yet unfortunately, particles that consist of just enzymes and diblock copolymers are not very robust. Lindhoud therefore substituted a part of the enzymes with a polymer of the same charge. This improved the stability and robustness of the particles. Moreover, Lindhoud discovered that the enzymes preferred not to be located in the core of the particle but on the boundary of this instead. Adding polymers with the same charge increased the surface of this boundary.

The advantage of enzymes packaged using Lindhoud’s approach is the ease with which these can be unpackaged again. This is essential for the effective use of enzymes in industrial applications. Lindhoud’s research could therefore do more than improve detergents; it could enable new applications of enzymes. One such possible application is the specific delivery of medicines.

Saskia Lindhoud carried out her research with a TOP grant from the NWO Division for the Chemical Sciences. She is now a postdoctoral researcher at the University of Bath.

On the Net:

Immune System Quirk Could Lead To Effective Tularemia Vaccine

Immunologists at the University of Pittsburgh School of Medicine and Children’s Hospital of Pittsburgh of UPMC and the have found a unique quirk in the way the immune system fends off bacteria called Francisella tularensis, which could lead to vaccines that are better able to prevent tularemia infection of the lungs. Their findings were published today in the early, online version of Immunity.

F. tularensis is an intracellular pathogen that infects cells in the lungs called macrophages, explained senior author Shabaana A. Khader, Ph.D., assistant professor of pediatrics and immunology at the School of Medicine and an immunologist at Children’s Hospital. Until now, scientists thought that eliciting a strong immune response to clear the infection would only require activation of a cytokine protein called interferon gamma (IFN-gamma). But that’s not true for F. tularensis as it is for other intracellular bacteria, such as the TB-causing Mycobacterium tuberculosis.

“Our lab experiments show that in order to activate IFN-gamma in pulmonary tularemia, it is necessary to first induce production of another cytokine called interleukin-17,” Dr. Khader explained. “So if we want to make an effective vaccine against tularemia, we must target ways to boost IL-17.”

According to the U.S. Centers for Disease Control and Prevention (CDC), the virulent strain of tularemia commonly causes infection in wild animals, and about 200 human cases are reported annually in the United States. It can be spread through the bites of infected insects, the handling of sick or dead animals, eating or drinking bacteria-contaminated food or water, or by inhalation of airborne bacteria. Antibiotic treatment is effective.

Although not transmissible from person to person, it is highly infectious. Because only a small amount of the virulent bacteria can cause disease and spread through the air to cause severe respiratory illness, it could be a candidate for a bioweapon, the CDC has noted. A safe, lab-adapted live vaccine strain was used in Dr. Khader’s study.

Dr. Khader’s team will continue its work by studying how to target lung IL-17 responses to develop vaccine strategies for pulmonary tularemia.

On the Net:

NICE Solution To Pneumonia Vaccine Testing Problems

Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology (NIST), where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB).

Pneumonia is the world’s leading cause of death in children under five years of age and poses a serious risk to elderly adults. The leading cause of pneumonia worldwide is the pneumococcus bacterium, which also causes meningitis, sepsis and other complications. Pneumococcus has more than 90 strains that vary by geographic region and change over time. Consequently, ongoing testing is necessary to monitor existing vaccines and advance new ones.

One novel, high-throughput testing method involves culturing the bacteria along with a vaccinated person’s blood serum and human white blood cells. If the vaccine is effective, the white cells kill the pneumococci and very few of the bacteria survive. Scientists can determine the vaccine’s effectiveness by counting the number of surviving pneumococcus colonies, so rapid, accurate and standardized counting of these colonies is critical to this testing method.

At present, the most commonly used counting process is manual counting, which is both time-consuming and exhausting. “Automated counting devices do exist, but they require customized image acquisition methods, are very expensive and are not accessible in impoverished or developing regions of the world. These limiting factors can mean the difference between life and death,” says NIST biophysicist Jeeseong Hwang. “So we created software that can be tweaked to work on any common imaging device.”

The open-source software, called NIST’s Integrated Colony Enumerator (NICE), takes a digital image that has been loaded into a computer and counts colonies grown from single pneumococcal cells. The Microsoft Windows-based software works on images from both digital cameras and flatbed scanners, which are widely available and inexpensive, costing less than $1,000 each. “NICE obtains results that agree well with manual counting, the current gold standard,” says Matthew Clarke, who developed the program algorithm and code in Hwang’s group. “There’s a mean difference of only 3 percent between the two methods.”

The project grew from informal talks between NIST and UAB, where researcher Moon H. Nahm developed the testing method. Nahm has been working with vaccine testing methods to support projects by the National Institutes of Health and PATH, a nonprofit organization dedicated to improving health in poor communities around the world. As NIST scientists have been developing ways to standardize counting particles, PATH provided funding and worked with NIST. After 18 months of effort, NICE is now ready.

“We have already identified several clinics in Asia, where we feel many of the potential users are,” Hwang says. “We’re hoping to get feedback from them so we can improve the software in the future.”

* The two software files required to run NICE, along with additional images demonstrating their use, can be downloaded at ftp://ftp.nist.gov/pub/physics/mlclarke/NICE. The files, written in the language MATLAB R2008B, are MCRInstaller.exe (MATLAB compiler engine 7.9) and NICE_B1r.exe (launches NICE). Further information is available from the programmer at [email protected].

Image 1: Pneumococcus colonies (as seen here) ordinarily must be counted manually to determine whether pneumonia vaccine is effective on a patient. The NICE software from NIST automates the process. Credit: NIST

Image 2: Pneumococcus colonies ordinarily must be counted manually to determine whether pneumonia vaccine is effective on a patient, but freely available NICE software developed at NIST will help automate the process, potentially saving many lives in the world’s developing regions. Credit: NIST

On the Net:

Weather Patterns, Seasons Shape Our Internal Body Clock

Scientists have discovered that our internal body clocks are shaped by the weather and the different seasons, BBC News reported.

A team of researchers from Edinburgh University used computers to model the workings of internal biological clocks in human test subjects.

The study helped determine that the internal clock mechanism is very complicated because it is able to deal with varying amounts of light from hour to hour, as well as changing seasons.

The team hopes that their findings may benefit research studies attempting to solve sleep problems caused by jet lag and shift working.

The discoveries also offer a better understanding of what drives the internal rhythms of people, animals and plants.

Experts also determined that environmental signals, such as hours of daylight, affect the daily rhythms that many plants use to control the flowering and ripening process.

Scientists might even be able to develop crops that can cope with climate change in the future.

The study also involved researchers from the California Institute of Technology and the University of Warwick.

“By better understanding why biological clocks are so complex, we stand a better chance of controlling them,” said Dr Carl Troein of the University of Edinburgh’s School of Biological Sciences.

He added that the study goes some way to explaining how and why these in-built rhythms have developed over time.

“We hope it will be useful in informing treatments for sleep disorders as well as helping scientists develop crops that can survive in the long term,” he said.

On the Net:

Can We ‘Learn To See?’: Study Shows Perception Of Invisible Stimuli Improves With Training

Journal of Vision article suggests potential treatment for blindsight patients

Although we assume we can see everything in our field of vision, the brain actually picks and chooses the stimuli that come into our consciousness. A new study in the Association for Research in Vision and Ophthalmology’s Journal of Vision reveals that our brains can be trained to consciously see stimuli that would normally be invisible.

Lead researcher Caspar Schwiedrzik from the Max Planck Institute for Brain Research in Germany said the brain is an organ that continuously adapts to its environment and can be taught to improve visual perception.

“A question that had not been tackled until now was whether a hallmark of the human brain, namely its ability to produce conscious awareness, is also trainable,” Schwiedrzik said. “Our findings imply that there is no fixed border between things that we perceive and things that we do not perceive ““ that this border can be shifted.”

The researchers showed subjects with normal vision two shapes, a square and a diamond, one immediately followed by a mask. The subjects were asked to identify the shape they saw. The first shape was invisible to the subjects at the beginning of the tests, but after 5 training sessions, subjects were better able to identify both the square and the diamond.

The ability to train brains to consciously see might help people with blindsight, whose primary visual cortex has been damaged through a stroke or trauma. Blindsight patients cannot consciously see, but on some level their brains process their visual environment. A Harvard Medical School study last year found that one blindsight patient could maneuver down a hallway filled with obstacles, even though the subject could not actually see.

Schwiedrzik said the new research may help blindsight patients gain conscious awareness of what their minds can see, and he suggested that new research should address whether the brains in blindsight patients and people with normal vision process the information the same way.

“Our study suggests that it might in principle be possible for blindsight patients to recover some visual awareness, and thus our findings might open a venue for a new line of research and potential treatments for patients with acquired cortical blindness,” Schwiedrzik said.

On the Net: